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Aqueous core colloidosomes with a metal shell 
Qian Sun 
Colloidosomes are microcapsules whose shells consist of colloid particles, which are 
coagulated by a stabiliser or fused by sintering. In recent years, they have attracted 
considerable attention because of their potential applications in a range of industries, such 
as food, bioreactors and medicine. However, traditional particulate polymer shell 
colloidosomes leak low molecular weight encapsulated materials due to their intrinsic shell 
permeability, and this problem will limit their applications in pharmaceutical industries.  
In this thesis, we report aqueous core colloidosomes coated with a silver or gold shell, which 
make the capsules impermeable. The shells can be ruptured using ultrasound. The silver 
shells are prepared by making an aqueous core capsule with a particulate polymer shell and 
then adding AgNO3, surfactant and L-ascorbic acid to form a second shell. The gold coated 
colloidosomes are prepared by making an aqueous core capsule with a particulate polymer 
shell and then adding HAuCl4, surfactant and L-ascorbic acid.  
We propose to use the metal coated capsules as drug carriers to load an anticancer drug, 
doxorubicin. After triggering by ultrasound, encapsulated drug, broken fragments and 
possibly some drug attached on the surface of the capsules may all kill cancer cells. For 
silver coated colloidosomes, at 10 capsules/cell, they have a low cytotoxicity, showing a cell 
viability of more than 90% during the first 24 h and more than 60% after 72 h. Increasing 
the number of capsules, the cytotoxicity of the silver shells increases heavily. Compared 
with silver ones, the gold shells show less toxicity to cells. We also used the capsules to load 
an antibiotic kanamycin and triggered to release the drug and kill E.coli. 
In addition, we set up a targeting model by modifying the colloidosomes using 4,4’-
dithiodibutyric acid and attaching them with proteins - rabbit Immunoglobulin G (IgG). 
Label-free Surface Plasmon Resonance biosensor was used to test the specific targeting of 
the functional silver or gold shells with rabbit antigen. The results demonstrate that a new 
type of functional metal coated colloidosome with non-permeability, ultrasound sensitivity 
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1.1 Encapsulation  
Polymer shell microcapsules with liquid cores have attracted interest in recent years because 
of their capability for encapsulating and delivery of useful materials. [1, 2] They can be used 
in a wide variety of industries, such as food [3], medicine [4], bioreactors [5], and cosmetics [6]. 
Here we introduce the reasons for encapsulation, encapsulation methods, and some release 
mechanisms. 
1.1.1 Reasons for encapsulation 
Encapsulation causes interest in many industries. [1-6] The main reason is that microcapsules 
can isolate the core from its surroundings to protect it from harsh environments, such as pH, 
temperature, solvents and poisons. [7] For example, in some biological systems, the capsules 
can seal and protect enzymes or bacteria from denaturing by solvents, which can result in 
greater cell viability and bioreactor productivity. [5, 8-11] 
In addition, encapsulation allows for controlled delivery of encapsulated materials to 
targeted areas, then release of the encapsulated ingredient. For example, in some 
pharmaceutical systems, sealing active drug species inside a particle or capsule, as drug 
delivery vehicles, with well-defined release properties is often the preferred treatment 
method. [12] In agricultural and environmental applications, aqueous core colloidosomes can 
be used to deliver potentially toxic materials, such as pesticides and herbicides to their 
intended environments. [13] 
A further reason for encapsulation is to delay external chemical reactions until suitable 




in turn, maintains product quality. For example, in pharmaceutical applications, water core 
microcapsules can be used to delay the release of an active drug species. [8] 
1.1.2 Encapsulation methods 
Various preparation methods of encapsulation have been reported and developed, such as 
liposomes [14], silica shell microcapsules [15, 16], dendrimers shell microcapsules [5], and 
particulate polymer shell microcapsules [17, 18]. In biological applications, aqueous core 
microcapsules are widely used for encapsulation and show great potential. In this section, a 
few common aqueous core microcapsule preparation methods are introduced, including self-
assembly colloidosomes, layer-by-layer polyelectrolyte deposition, polymer precipitation by 
phase separation, polycondensation interfacial polymerization, and polymeric vesicles. [19]  
1.1.2.1 Colloidosomes 
Colloidosomes are microcapsules whose shells consist of colloid particles, which are 
coagulated by a stabiliser or fused by sintering. [19] Fig. 1.1 shows a general overview of the 
fabrication method of colloidosomes. An aqueous suspension of colloidal particles is 
emulsified in an oil phase. The colloidal particles, with both hydrophobic and hydrophilic 
groups, move to the water-oil boundary. The stability will be provided using a stabiliser to 
lock the particles, or heating to let the particles melt. Velev et al. [20, 21] made the first 
colloidosomes by emulsifying oil phase droplets in an aqueous suspension of polystyrene 
particles. The polymer particles coated the emulsion droplets and made the colloidosomes 
stable. Further research continued to fabricate colloidosomes using a direct self-assembly 
method [22, 23] and improved the size distribution of the fabricated colloidosomes [24, 25].  
The self-assembly approach is suitable for biological encapsulation since there is no contact 
with harsh solvents and it is possible to control the shell permeability. The disadvantage is 




that the colloidosomes prepared by this method need a further shell stabilization stage to 
make a robust structure. In addition, during the process of encapsulation, there may be 
leakages or core contamination because of incomplete shell formation.  
1.1.2.2 Layer-by-layer polyelectrolyte deposition 
Another common encapsulation method is layer-by-layer polyelectrolyte deposition. Fig. 
1.2 shows a general overview of the fabrication method. [26] This method places a charged 
particle in a polyelectrolyte solution of the opposite charge and the electrostatic driving force 
drives the polymer to form a stable film. The system is cleaned, and then, another layer is 
deposited. In some cases, the core is dissolved and hollow structure microcapsules obtained. 
[27-30]  
This approach is also suitable for biological encapsulation since there is no contact with 
harsh solvents and it is possible to control the thickness of the capsule shells by controlling 
the number of polyelectrolyte layers [31, 32]. However, this method needs a relatively long 
time to form capsules, since it involves multiple deposition and particle cleaning steps.  
Fig. 1.2 A general overview of the fabrication of microcapsules using a layer-by-layer 




1.1.2.3 Polymer precipitation by phase separation  
Liquid core capsules can also be formed using a polymer precipitation by phase separation 
method. There are two approaches for this method, including polymerization induced phase 
separation [33-35] and solvent extraction and evaporation [36-39]. The principle of the 
encapsulation process using the polymerization induced phase separation method is shown 
in Fig. 1.3. Initially, a mixture of water with a chosen surfactant is added into a hydrophobic 
monomer using ultrasonication for monomer polymerization and segregation. The 
morphology of the demixing structure is determined by the type of surfactant and the degree 
of engulfing is determined by the monomers. The non-engulfing and partial engulfing cases 
do not form capsules; only the complete engulfing case results in a capsule. [33-35] 
For solvent extraction and evaporation, the shell-forming polymer is dissolved in a solvent 
mixture comprising a volatile solvent and an involatile non-solvent. Then the solution is 
dispersed into a water/stabilizer mixture to produce an oil-in-water emulsion. The volatile 
solvent is then removed to form a hollow structure capsule. [36] The principle of the 
encapsulation process using solvent extraction and evaporation is shown in Fig. 1.4. The 
polymer precipitation by the phase separation method is more suitable for oil core 
encapsulation, and, it can produce microcapsules with relatively thick shells and narrow size 
Fig. 1.3 Schematic of steps for aqueous core microcapsules using polymerization induced phase 




distributions. The disadvantage is that volatile organic solvents are used during the 
microcapsule formation, which may be harmful for the encapsulated active materials. 
1.1.2.4 Polycondensation interfacial polymerization 
In classical interfacial polycondensation, there are normally two steps: firstly, oil in water 
emulsion droplets are formed using mechanical stirring and the monomer is enclosed in the 
emulsion drops. Then the second complementary monomer is added to the external phase of 
the emulsion and a polycondensation reaction takes place at the liquid-liquid emulsion 
interface. [40] The first emulsification step determines the capsule size and distribution. [41-45] 
Fig. 1.5 shows a schematic of the polycondensation formation of shells around emulsion 
droplets. [19]  
The advantage of this method is that it is suitable for both oil and aqueous cores, and the 
fabrication procedure is simple. However, the use of monomers limits the application of the 
capsules and it is difficult to achieve biological encapsulation using this method.  
Fig. 1.5 Schematic of the polycondensation formation of shells around emulsion droplets (image 
reproduced from Yow & Routh, 2006 [19]). 
Fig. 1.4 Schematic of steps for aqueous core microcapsules using solvent extraction and 




1.1.2.5 Polymeric vesicles 
Fig. 1.6 shows a schematic for the formation of polymersomes or polymeric vesicles from 
water-in-oil-in-water drops. [46] To form polymersomes with a diameter of 10-100 μm, one 
uses water-in-oil-in-water double emulsion drops of controlled architecture as templates. 
Then a volatile organic solvent is used as the middle phase and evaporation of the solvent 
leads to polymersome formation. [46]  
This method offers the advantages of high encapsulation efficiencies, and controllable 
vesicle sizes and architectures. [47-49] In addition, polymeric vesicles improve stability and 
lower permeability compared to lipid vesicles and can be used for biomedical applications. 
[50, 51] However, the downside is the number of vesicles formed, since this is limited by 
droplet formation. 
1.1.3 Release mechanisms and methods 
After sealing the encapsulated materials, it is necessary to find a suitable method to trigger 
a release from the capsules. According to different mechanisms, the release methods can be 
divided into three ways, including physical, chemical and biological methods.  
Firstly, the most common release method is physical. It uses an applied shear, pressure or 
other force, and results in shell rupture or mechanical deformation. For example, Gordon et 
al. [52] fabricated capsule adsorption to colloids and then triggered the contents by osmotic 
pressure from internal free polyelectrolytes. Keen et al. [10] synthesized aqueous core 
colloidosomes coated with calcium carbonate and used a shear force to break the capsules. 
Alternatively, Sun et al. [53, 54] and Gao et al. [55, 56] controlled the release of cargos in capsules 
Fig. 1.6 Schematic for the formation of polymersomes from water-in-oil-in-water drops (image 




using ultrasound. Skirtach et al. [57] presented a method for remote release of an encapsulated 
material from polyelectrolyte capsules based on laser light illumination. 
Another way to achieve release from the capsules is a chemical method. This can be carried 
out by melting, solvent action, hydrolysis, slow disintegration, chemical or photochemical 
reaction to dissolve or swell the shells. [19] For instance, Sun et al. [58] released sealed dye 
solution in silver shell capsules by addition of acid. Chiwele et al. [59] dissolved 
hydroxypropyl methylcellulose (HPMC) capsule shells rapidly in the dissolution medium 
with a pH below 5.8. Gun et al. [60] achieved a release of blue dye from the capsules when 
the pH was below 3.5, due to swelling of a particulate polymer shell. Kim et al. [61] used pH 
to swell polyelectrolyte multilayer microcapsules filled with dye solutions.  
A third way to release from the capsules is a biological method, such as enzymatic attack. 
For instance, De Geest et al. [62] demonstrated the release by enzymatic reactions and 
monitored profiles. In addition, there are various enzymes used for release, such as dextran 
sulfate and poly-L-lysine. [62-64] 
1.1.4 Prevention of small molecule leakage 
Traditional particulate polymer shell capsules may leak low molecular weight encapsulated 
materials in a short time due to their intrinsic shell permeability, and this problem will limit 
their applications in pharmaceutical industries. In recent developments of microcapsules, the 
control of capsule permeability has become a rapidly growing research area, with the aim of 
preventing the leakage of small molecule materials.  
For particulate polymer shell capsules, in order to have a long-term encapsulation and 
change the capsule permeability, the idea of forming a second shell to cover the original 
polymer was applied by many researchers. For example, Hitchcock et al. [65, 66] formed an 
impermeable metal film around polymer microcapsules using a three-step process. Their 
impermeable metal film can prevent leakage of small volatile oils in an ethanol phase for at 
least 21 days. However, the original polymer shell capsules lose the small volatile oils in 
less than 30 min under the same conditions. Keen et al. [10] used a precipitation method to 
synthesise a calcium carbonate shell, which was formed using an inner phase of sodium 
carbonate in the core of the polymer shells and an outer phase of calcium chloride. This 




molecules for a few months. Gao et al. [55] used the layer-by-layer assembly method to form 
polyelectrolyte microcapsules, then coated a silica shell. This polyelectrolyte/silica 
composite microcapsules can seal cargoes for up to 72 h.  
An alternative way to prevent the leakage of small molecule materials from polymer shell 
capsules is to change the shell thickness or layer structure, resulting in changing the 
permeability. For instance, Mendelsohn et al. [67] made polyelectrolyte capsules using a 
layer-by-layer assembly method, and then adjusted the pH to make shells with a selective 
thickness. Under different pH conditions, the thickness of the shell, which adsorbed 
polycations or polyanions, was between 0.5 and 8 nm. Ameloot et al. [68] formed capsules 
using self-completing growth of MOF layers. To control the thickness of the capsule shell, 
they used small inter-grown crystals to seal the gaps between larger crystals, and, finally 
obtained a uniform capsule shell  thickness between 1.5 and 2 mm. Ochs et al. [69] also 
formed multiple-layer film capsules using a layer-by-layer assembly method, and loaded 
inorganic colloidal, magnetic or plasmonic nanoparticles to control the thickness. Antipov 
et al. [70] made polyelectrolyte multilayer capsules, and they controlled the capsule 
permeability using different pH and salt concentrations.  
 
1.2 Materials for drug delivery 
Small drug molecules play an important role in medical applications and are widely used in 
the pharmaceutical industry. Drug delivery systems are routinely used to treat various 
diseases including cancer, fungal infections and muscular degeneration. [71, 72] The drug 
delivery vehicle should display a sufficient circulation lifetime to allow successful delivery 
to the targeted region. Furthermore, for toxic drugs, encapsulation in drug carriers reduces 
the harmful side effects. [73, 74] The trend of developing new drug delivery systems shows 
great commercial value and academic significance. It is reported by Research and Markets 
that the world drug delivery technology market will grow from $178.8bn in 2015 to 
$227.3bn in 2020, with an annual growth rate of 4.9%. [75, 76] Therefore, using drug carriers 
for drug delivery is becoming a rapidly growing research area. Below, a few common drug 
delivery materials are introduced, including polymers, particulate polymer shell capsules, 





1.2.1 Polymers and particulate polymer shell capsules 
Polymers have been widely used in pharmaceutical applications for encapsulation in drug 
delivery vehicles. [77, 78] The drug delivery system should not only have the ability to seal the 
drugs, but should also control the delivery and release. They can effectively deliver the drug 
to a target site and, thus, increase the therapeutic benefit and minimize side effects. [79] 
Currently, various polymers have been used in drug delivery research, such as poly (lactic 
acid) (PLA) [80-83], poly (glycolic acid) (PGA) [84-87], and their co-polymers poly (lactide-co-
glycolide) (PLGA) [88-91]. Fig. 1.7 shows the structures of these polymers, which are well 
known for both biocompatibility and resorbability through natural pathways. [92] In addition, 
particulate polymer shell capsules and emulsions have been developed and used for 
delivering drugs to targeted areas. [93-98] In these cases, the polymers shells are degradable, 
making them suitable for biomedical applications. However, encapsulation of small 
molecule drugs within particulate polymer shells presents a significant challenge. Most 
polymer capsule shells, due to their intrinsic high permeability, tend to leak small molecules. 
This greatly limits their practical application. 
1.2.2 Liposomes 
Liposomes are composed of phospholipids, which self-enclose to form spheres of lipid 
bilayers and an aqueous core within the bilayers. [99] Fig. 1.8 shows a typical liposome, and 
a portion of a typical lipid with multifunctional surface modifications. As drug carriers, 
liposomes can improve solubility of encapsulated drugs, have a good compatibility with 
biodegradable and nontoxic materials, and, also have a good versatility when chemically 
modified with attached specific surface ligands for targeting. [99-102] To use liposomes 
effectively, challenges, such as difficulty in targeting specific tissues and limitation of shelf-
life, need to be solved.  
Fig. 1.7 Chemical structure of (a) PLA, (b) PGA, and (b) PLGA monomers (image reproduced from 




1.2.3 Metal-organic frameworks 
Metal-organic frameworks (MOFs) are a new type of porous material, which consist of 
metal-containing nodes and organic linkers. [103] MOFs have a high structural flexibility, 
which enables the adaptation of their porosity to the shape of the host molecule. [104, 105] In 
addition, MOFs show simultaneously hydrophilic and hydrophobic abilities. Their tuneable 
pore size and connectivity can be adapted to the physicochemical properties of drugs in 
medical applications. [106-108] Based on their special structure, MOFs can be used as drug 
delivery vehicles for the encapsulation and delivery of drugs. [109, 110] Fig. 1.9 shows a 
schematic diagram of iron carboxylate MOFs for drug delivery. [106] When using MOFs as 
non-toxic drug carriers, issues, such as them not being compatible for biomedical and 
pharmaceutical applications, need to be solved.  
Fig. 1.8 A typical liposome, and a portion of a typical lipid with multifunctional surface modifications 
(image reproduced from Pattni et al., 2015 [99]). 
Fig. 1.9 Schematic diagram of iron carboxylate MOFs for drug delivery (image reproduced from 




1.2.4 Silica particles  
Silica particles have been widely developed in biological applications, since they are 
biocompatible and stable. [111] In addition, bioactive molecules can be easily encapsulated 
within silica particles by combining sol-gel polymerization with either spray-drying or 
emulsion chemistry. [112] The silica sol-gel fabrication process is easy and cheap. Moreover, 
the reaction conditions are relatively mild. Normally, silica particles can be prepared using 
Tetraethyl Orthosilicate (TEOS) in an ethanol/water medium [113, 114], or using silicic acid 
and sodium hydroxide [115].  
For a drug delivery system, mesoporous silica nanoparticles are more often used, due to their 
high specific surface area and volume which enables them to load drugs. [116, 117] In addition, 
silica structures can be easily functionalized using precursors with desired functional groups. 
For examples, the hybrid silica monolith, which was conveniently synthesized by hydrolysis 
and polycondensation, can be functionalized with octyl and thiol groups. [118] The silica gel 
can be easily functionalized with various organic compounds with metal chelating ability as 
well. [119] However, the addition of such functional groups changes the final structure such 
as the pore size of the mesoporous silica, which will affect the loading capacity.  
1.2.5 Nanoparticles 
Nanoparticles are particles between 1 and 100 nanometers (nm) in size. Nanoparticles have 
many special properties, such as the small size, customized surface, multi-functionality and 
improved dispersibility. These properties highlight the potential to use nanoparticles as 
multifunctional drug carriers for biomedical applications. [120] For instance, some polymeric 
nanoparticles have a good stability and their surfaces are easily modified, so it is possible to 
use these polymeric nanoparticles as drug carriers to achieve both controlled drug release 
and disease-specific localization by adapting their surface chemistry. [121-123] Magnetic 
nanoparticles, such as iron oxide nanoparticles with or without a polymeric coating, are often 
used for current clinical diagnostic and therapeutic, magnetic resonance imaging, and also 
as drug carriers [124]. In addition, carbon nanomaterials, such as carbon nanotubes and 






A micelle is a surfactant structure of molecules containing both a “hydrophilic head” and 
“hydrophobic tail”. Normally, a micelle in aqueous solution forms an aggregated hydrophilic 
part contacting with the solvent, and isolates a hydrophobic single-tail part in the micelle 
centre [127]. Among different kinds of micelles, block-copolymer micelles are often used as 
drug carriers. These micelles are a spherical super-molecular gathering of “amphiphilic 
copolymers”. [128] Amphiphilic block copolymers can contain hydrophobic drugs in the core, 
and their shells are hydrophilic, so they can be used as modules for the delivery of poorly 
soluble contents. The chemical composition, total molecular weight, and ratios of 
amphiphilic block copolymers can be easily adjusted, in order to control the size and 
morphology of the micelles. [129, 130] This feature makes micelles suitable for drug delivery 
applications.  
1.2.7 Hydrogels 
A hydrogel is a cross-linked network of water-soluble polymers, which can also be used for 
encapsulation and delivery of drugs. [131] Functional hydrogels, such as environmentally 
sensitive hydrogels, have potential in medicine and pharmaceutical applications. For 
example, pH-sensitive or temperature-sensitive hydrogels can be used for site-specific 
controlled drug delivery, by adjusting to a different pH or temperature. Specific molecule-
sensitive (glucose or antigens) hydrogels can be used as biosensors or for drug delivery 
systems. Light-sensitive, pressure-responsive and electro-sensitive hydrogels also have the 
potential to be used for drug delivery and bioseparations. [132] 
 
1.3 Targeted drug delivery 
Targeted drug delivery is a method of delivering drugs to specific regions in the body. 
Recently, targeted drug delivery has become a rapidly growing research area, since effective 
delivery is an important part of drug development. [133] Targeted delivery can usually be 




Passive targeting means that the drug carriers passively reach the targeted organ or tissues. 
In this method, the drug carriers are usually macromolecules or nanoparticles, which contain 
therapeutic agents. For example, one can use catheters to infuse nanoparticles drug carriers 
to the targeted organ or tissues. In addition, one can enhance permeability and retention 
effect to deliver the drug. [134, 135] Active targeting means that the drug carriers are actively 
targeted towards the relevant organ or tissues. After loading the therapeutic agent, the drug 
carriers are normally combined with a cell-specific ligand. [136] For example, the drug 
carriers can bind to complementary receptors on cells, so that the receptors can guide the 
drug carrier system to the diseased tissues. [137] Another way to achieve active targeting is to 
use magnetic positioning. One can combine magnetic particles with drug-containing 






1.4 Experimental methods 
The main experimental methods used in this research are introduced in the following 
description, including scanning electron microscopy, energy-dispersive X-ray spectroscopy, 
transmission electron microscopy, confocal laser scanning microscopy, fluorescence 
microscopy, surface plasmon resonance, ultrasound, UV-Vis spectrophotometry, and Raman 
microscopy. 
1.4.1 Scanning electron microscopy  
A scanning electron microscope (SEM) is a type of microscope which produces images of 
samples by scanning the surface with a focused beam of electrons. SEM is often used in 
materials science to test the morphology and the structure of different samples. Normally, 
SEM samples are dried and coated with a gold or platinum film before measurement. In a 
typical SEM, a beam of electron is focused on a very small spot and moved over each point 
of the subject. [138, 139] Fig. 1.10 shows a schematic of a typical scanning electron microscope. 
[140] 
Conventional SEM is used to examine dried samples in a high vacuum. For wet conditions 
in a low vacuum, an environmental scanning electron microscopy (ESEM) is used. Fig. 1.11 
Fig. 1.10 Schematic of a typical scanning electron microscope (image reproduced from Kapp et al., 




shows a schematic representation of an environmental scanning electron microscope. [141] 
The main distinguishing features of ESEM compared to other electron microscope 
techniques is the presence of vapour (usually water) in the sample chamber and there is no 
need for prior sample preparation. [142] 
In our research, a Zeiss X-beam FIB SEM was used at an accelerating voltage of 5.0 kV. For 
sample preparation, a drop of particle suspension was air-dried on a stainless steel SEM stub 
overnight. The particulate polymer shell colloidosome samples were gold-coated using a 
BioRad SEM sputter coater, in an argon environment at 1×10-3 mbar and 10 mA for 180 s. 
The gold and silver coated colloidosome samples were imaged without any treatment. 
1.4.2 Energy-dispersive X-ray spectroscopy 
An energy-dispersive X-ray spectroscope (EDS, EDX, EDXS or XEDS) is an analytical 
technique for analyzing the elemental composition of samples. The EDX is used in 
combination with an electron microscope, normally a transmission electron or scanning 
electron microscope. [143, 144] It is used to find out which elements are present in the sample 
as well as their amounts. [145] In our research, the energy-dispersive X-ray spectroscopy we 
used is in combination with a Zeiss X-beam FIB scanning electron microscope. The 
accelerating voltage used for EDX analysis was 10.0 kV. 
  
Fig. 1.11 Schematic representation of an environmental scanning electron microscope (image 




1.4.3 Transmission electron microscopy 
A transmission electron microscopy (TEM) is a type of microscope where a beam of 
electrons is transmitted through a sample to form an image. TEM is also often used in 
materials science to test the morphology and structure of different materials. It is capable of 
taking images at a significantly higher resolution than SEM and normal optical microscopes, 
especially for high resolution observation such as for nanoparticles. [146, 147] Fig. 1.12 shows 
a schematic representation of a transmission electron microscope. [148]. In our research, the 
transmission electron microscope we used is an FEI Philips Tecnai 20 TEM at 200 kV 
(Tungsten, LB6) high-energy electron beam. For sample preparation, a drop of colloidosome 
sample was added onto a TEM grid, and then transferred to the specimen holder.  
  
Fig. 1.12 Schematic representation of a transmission electron microscope (image reproduced from 




1.4.4 Confocal laser scanning microscopy 
A confocal laser scanning microscopy (CLSM) is a kind of optical imaging microscope, 
which can increase optical resolution and contrast using a spatial filter to block out-of-focus 
light, and it also uses fluorescence to generate an image. [149, 150] In an image forming process, 
the sample is scanned point by point by the light beam. Only the focused point light source 
is collected by the detector, and the out-of-focus light is not collected. [149, 151] For every 
measurement, three types of images, including optical, fluorescent and merged, can be 
obtained. CLSM is widely used in biological applications, such as cell biology and genetics. 
It is also used in nano-crystal imaging and spectroscopy. [152] In our research, the confocal 
laser scanning microscopy we used is a Leica TS confocal scanning system (Leica, Germany) 
equipped with a 63×/1.4 oil immersion objective. 
1.4.5 Fluorescence microscopy 
A fluorescence microscope is a kind of optical microscope, which uses fluorescence or 
phosphorescence for reflection and absorption to study properties of samples. Actually, any 
microscope, which uses fluorescence to generate an image, is referred to as a fluorescence 
microscope, including the confocal microscope introduced above. [153, 154] Fluorescence 
microscopy is widely used in biological studies for observation. [155] For every measurement, 
the operator can get both optical and fluorescent images. In our research, the fluorescence 
microscope we used is a Nikon EFD-3 fluorescence microscope with a flourescein 
isothiocyanate filter (excitation 510-560 nm, dichroic mirror 575 nm, barrier filter 590 nm). 
1.4.6 Surface plasmon resonance 
Surface plasmon resonance (SPR) is a strong electromagnetic oscillation of electrons which 
can happen at a metal/dielectric interface. [156] The SPR wave is very sensitive to the 
refractive index change between the metal and the dielectric. [157] There is an incident light 
in a typical SPR. When the energy and momentum of the incident light matches the 
electromagnetic wave of SPR, then a surface plasmon resonance occurs at the interface of 
the two media provided their dielectric constants are of opposite signs - this occurs for a 
metal (typically gold or silver) and a dielectric. [158] The light energy from the incident 
photons links with the electrons in the metal to create a sharp resonant dip in the light 




refractive index of the surrounding medium. Therefore, even if there is a very small change 
of the refractive index near the metal layer, SPR provides a measurable shift in the resonance. 
[156-159] Fig. 1.13 shows a typical configuration for the exciting surface plasmon, which is the 
most widely used optical platform for SPR sensing. [160] In the diagram, q stands for the 
metal thickness, x and y refer to the coordinate system, εp, εm, εd are the permittivity of the 
prism, metal and dielectric respectively. [160] 
As mentioned above, SPR is very sensitive to the refractive index of materials near a thin 
metal film, so it is used for many biosensor applications. Label-free SPR sensors have been 
developed and commercially used in recent years. It is possible to detect small 
concentrations of analytes, in a wide range of medical and scientific applications. [161-163] 
SPR biosensors have also been used to study the interactions of numerous biomolecules, 
such as deoxyribonucleic acid, proteins, enzymes, antibodies, and antigens. [164, 165] For 
examples, an SPR biosensor converts a biological reaction into a physiochemical signal such 
as a colour change or electric potential variation, by binding the surface with an analyte and 
a capture ligand.  
In our research, we used a custom-made spectral SPR biosensor to monitor the targeting 
experiment. [54, 166] The biosensor setup was built and provided by Prof Lisa Hall from the 
Analytical Biotechnology Group at the University of Cambridge. Fig. 1.14 shows the 
schematic diagram of the spectral SPR sensor. 
Fig. 1.13 Typical configuration for exciting surface plasmon. In the diagram, “q” is the metal 
thickness, “x” and “y” refer to the coordinate system, “εp” , “εm”, “εd” are the permittivity of the prism, 




1.4.7 Dynamic light scattering 
Dynamic light scattering (DLS) is used to determine the size distribution of particles in 
suspension. This method analyses intensity fluctuations of the light scattered due to motion 
in bulk materials. The theory of DLS utilizes a model system of spherical particles in a 
sample solution. [167] DLS is used in many fields, such as chemistry, biochemistry, and 
physics to determine the size distribution of particles like polymers, proteins and colloids in 
solution or suspensions. [168, 169] In our research, the diameter of the latex particles was 
determined by a Brookhaven ZetaPALS dynamic light scattering. 
1.4.8 Ultrasound device 
Ultrasound uses sound waves with frequencies higher than the upper audible limit of human 
hearing. Normally, ultrasound devices provide frequencies from 20 kHz up to several 
gigahertz and are used in many medical applications, such as ultrasound therapy [170] and 
diagnosis for some disease treatment [171].In our research, the ultrasound device was 
provided by Prof Gleb Sukhorukov from Queen Mary, University of London. We used an 
ultrasonic probe operating at a frequency of 20 kHz and power output of 50 W to monitor 
capsule rupture. The treatment was performed using an ultrasonic processor GEX 750 
(Sonics & Materials Inc., USA). In addition, we employed high intensity focused ultrasound 
Fig. 1.14 Schematic diagram of a custom-made spectral SPR sensor (device provided by Prof Lisa 




(HIFU) to break capsules. High intensity focused ultrasound is a non-invasive therapeutic 
technique, which uses high frequency sound waves to heat or destroy tissue. [172] High 
intensity beams can be produced using a lens to focus a suitable acoustic frequency to 
regions for tissue destruction. This method has been reported to reach at depths of up to at 
least 10 cm with exposure times of the order of 1 s. [173] Fig. 1.15 shows the home-made 
high intensity focused ultrasound device, which is also built and provided by Prof Gleb 
Sukhorukov. This set-up can produce ultrasound with a frequency of 2.65MHz and power 
output of 6 W, similar to some medical devices [174].  
1.4.9 Ultraviolet-visible spectrophotometry 
Ultraviolet-visible spectrophotometry (UV-Vis) is a technique for absorption or reflectance 
spectroscopy in the ultraviolet-visible spectral region. It uses light in both the visible and 
adjacent ranges. [175] For measuring, organic constituents are normally determined with UV 
light sources, and the visible part of the absorption spectrum is usually utilized for inorganic 
spectrophotometric analysis. [176] UV-Vis can be used for analytical chemistry of different 
analytes and the analysis is normally carried out in solution, but solids and gases may also 
be measured. [177] In our research, a UV-Vis spectrophotometer equipped with a tungsten 
lamp (Thermo Scientific, model Heλios Gamma) was used for spectrometry measurements. 
The dyed samples were characterized by spectrophotometry in 10 mm path length 
polystyrene cuvettes.  





1.4.10 Raman microscopy  
Raman spectroscopy is a technique for molecular identification, which provides information 
about functional groups. It is commonly used in chemistry applications to test the 
composition, bonding, chemical environment, phase, and crystalline structure of sample 
materials. [178, 179] Fig. 1.16 shows a schematic of a research-grade Raman microscope. [180] 
In a typical Raman microscope, samples are examined visually at high magnification, so 
specific areas can be chosen and analysed. In our research, to analyse the colloidosomes 
before and after modification, a LabRAM HR Evolution Raman Spectroscopy (HORIBA 
Scientific) was used.  
  
Fig. 1.16 Schematic of a research-grade Raman microscope (image reproduced from Smith & Clark, 




1.5 Aims and objectives  
The purpose of this research is to prepare colloidosomes coated with a metal shell, such as 
silver or gold, which make the particulate polymer shell colloidosomes impermeable. Then 
we investigated the loading of drugs into the capsules and the use of them as drug carriers. 
Fig. 1.17 shows a schematic representation of microcapsule encapsulation and release of 
small molecules. Particulate polymer shell capsules leak small molecules, whereas metal 
coated capsules remain impermeable and can be ruptured with ultrasound.  
The specific objectives were as follows: 
1. To prepare colloidosomes coated with a metal shell, such as silver or gold, which can 
make the particulate polymer shell colloidosomes impermeable. 
2. To load cargos in the impermeable colloidosomes and explore release mechanisms and 
methods. 
3. To set up a targeting model using a biosensor to see if the colloidosomes are able to be 
used as a targeted carriers for small molecule materials.  
4. To load different drugs, such as an anticancer drug or antibiotic, and together with a cell 
viability experiment, to see if the colloidosomes are able to be used as drug carriers. 
  





Chapter 2.  
 
Preparation of silver and gold coated 
colloidosomes 
 
The results from this chapter have been published in European Polymer Journal, Langmuir, 
and Soft Matter: 
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Routh. A Fabrication Method of Gold Coated Colloidosomes and Their Application as 
Targeted Drug Carriers. Soft Matter, 2018, 14(14): 2594-2603. 
 
2.1 Introduction 
This chapter describes the method for fabrication of aqueous core colloidosomes with a 
silver shell as well as a gold shell. This seals the core and makes the shell impermeable. The 
silver coated colloidosomes were prepared by making an aqueous core capsule with a 
particulate polymer shell and then adding AgNO3, surfactant and L-ascorbic acid to form a 
second shell. The gold coated colloidosomes were prepared by making an aqueous core 
capsule with a particulate polymer shell and then adding HAuCl4, surfactant and L-ascorbic 




coated colloidosomes to encapsulate cargos, such as dye solution, to test the release 
mechanisms.  
 
2.2 Experimental section 
2.2.1 Materials 
The water used in all experiments was deionized of resistivity 18.2 MΩ•cm produced by a 
Pure Lab Ultra apparatus. The vortex mixer was a TopMix FB15024 (Fisher Scientific). The 
dialysis tubing was Spectra/Por Dialysis membrane with a MWCO of 12000-14000 
(Spectrum Laboratories). Sodium dodecyl sulfate (SDS, Fisher Scientific), Allura Red AC 
(Sigma-Aldrich), L-ascorbic acid (Fisher Scientific), silver nitrite (Fisher Scientific), and 
gold chloride (Fisher Scientific) were used as received without purification. Here, Allura 
Red AC was used as a dye to test the release. The reason we used Allura Red AC is that 
this dye does not affect the colloidosome synthesis process, it is small enough to 
diffuse from the porous particulate polymer shells and it is not very pH sensitive. Fig. 
2.1 shows the chemical structure of Allura Red AC. 
Poly (methyl methacrylate-co-butyl acrylate) latex particles were synthesized by Polly Keen 
via emulsion polymerization [10]. Briefly, a pre-emulsion of seed particles (1.33 wt%) plus 
surfactants was made up in the reactor. Then the main process was carried out in semi-batch 
mode with a programmed feed to the reactor. The monomer and initiator were gradually fed 
into the reactor over 4 hours. The aqueous suspension of methyl methacrylate (MMA) and 
butyl acrylate (BA) were in the ratio of 65:35 by weight. Finally, the monomer chasers 




(redox initiators) were added at the end for reaction, and thus, devolatilize, any residual 
monomers and/or low molecular weight oligomers from the product via further 
polymerisation. Fig. 2.2 shows the chemical structure of methyl methacrylate and butyl 
acrylate.  
The diameter of the latex particles was determined by dynamic light scattering using a 
Brookhaven ZetaPALS. The measured diameter was 153 nm. The glass transition 
temperature of poly (methyl methacrylate-co-butyl acrylate) was found using differential 
scanning calorimetry to be 35 °C.  
To produce particulate polymer shell colloidosomes, an aqueous suspension of the particles 
was emulsified in sunflower oil and fused by sintering at 50 °C for 1 h. After sintering, the 
latex particles melt into smooth shells, and can be used as base capsules for forming a metal 
shell. Fig. 2.4 shows SEM images of particulate polymer shell colloidosomes. The diameter 
of the smooth particulate polymer shell capsules in Fig. 2.4a and b was between 0.7 µm and 
Fig. 2.3 SEM images of P(MMA-co-BA) latex particles . 




2 µm and the average diameter was around 1.2 µm. The thickness of the particulate polymer 
shells is the diameter of a single latex particle, about 153 nm.  
2.2.2 Fabrication of silver coated colloidosomes 
Fig. 2.5 shows a typical method for fabrication of the silver coated colloidosomes. 4 mL 
Span 80 was mixed with 200 mL sunflower oil in a 400 mL beaker using a Silverson high 
shear mixer (model SL2). 2 mL of 5.6 wt% latex particles was then added to the sunflower 
oil over 30 s. Cyclic mixing was employed, whereby homogenization was carried out for 60 
s, followed by 30 s rest. This was repeated five times. This process enabled emulsions 
droplets to be more uniform and smaller, since in every cycle the emulsions droplets will be 
cut into smaller ones. After emulsification, the emulsion was heated in a water bath at 50 ± 
0.5°C. Once the temperature inside the emulsion tubes reached 50 ± 0.5 °C, the timer was 
started, and the emulsions were sintered for 1 h. The aim of this process is to melt the latex 
particles into smooth shells.  
After sintering, 20 mL of the liquid mixture was transferred into an empty centrifuge tube 
and centrifuged at 2500 rpm for 10 min at 20°C. The waste oil, together with the small 
volume of water which had leaked out from the colloidosomes was removed via pipetting. 
After removing the oil phase, 24 mL of a 0.1 wt % aqueous solution of AgNO3 and 2 mL of 
a 1 wt% aqueous solution of SDS were added, and the mixture was agitated using the vortex 
mixer. SDS was used to avoid colloidosome aggregation. Addition of 2 mL of a 15 wt% L-
ascorbic acid aqueous solution started the silver reduction reaction, which was allowed to 





proceed for 1 h. To obtain the final aqueous dispersion of silver coated microcapsules, the 
mixture was centrifuged, at 20°C and 1500 rpm for 2 min followed by redispersal in a 0.1 
wt% SDS solution, used to avoid aggregation. 
2.2.3 Fabrication of gold coated colloidosomes 
Fig. 2.6 shows a typical method for fabrication of gold coated colloidosomes. The method 
was almost the same as producing silver coated colloidosomes. The difference is that 20 mL 
of a 1 wt % aqueous solution of HAuCl4 and 2 mL 1 wt% aqueous solution of SDS were 
added to the tube to make the gold shells, and the microcapsules were redispersed in the 
aqueous phase using a vortex mixer. Then 2 mL of a 15 wt% L-ascorbic acid solution was 
added to the tube and rested for 1 h, to allow the gold reduction reaction to occur. After the 
gold reduction reaction, the mixture was centrifuged at 1500 rpm for 2 min at 20°C to 
recover the sediment and the supernatant was removed via pipetting. The resulting gold 
coated microcapsules were washed and redispersed using a 0.1 wt% SDS solution, which is 
used to avoid aggregation of the gold coated colloidosomes. 
 
 




2.2.4 Release by ultrasonic treatment 
An ultrasonic probe, operating at a frequency of 20 kHz and power output of 50 W, was 
used to release the cargo from the colloidosomes, as shown in Fig. 2.7. Different times of 
application were employed using an ultrasonic processor GEX 750 (Sonics & Materials Inc., 
USA). The temperature change was kept below 5°C by using an ice bath.  
2.2.5 Dye encapsulation and dye release 
To encapsulate dye in the silver shell colloidosomes, a mixture of 5.6 wt% latex particles 
and 2 wt% Allura Red AC dye solution was prepared. Then 2 mL of this mixture was added 
Fig. 2.6 A typical method for fabrication of the gold coated colloidosomes. 




into a mixture of 4 mL Span 80 and 200 mL sunflower oil for emulsification and sintering. 
The waste oil phase was removed and the colloidosomes containing Allura Red AC dye 
were redispersed in AgNO3 solution, with subsequent addition of the L-ascorbic acid and 
SDS solutions, to form the silver shell, sealing the capsules. 
To measure the dye release, 20 mL samples were introduced into a dialysis tubing which 
was then kept into a larger container with 450 mL of water. A magnetic stirrer was employed 
and 3 mL samples from the container were taken for spectroscopic characterization at regular 
intervals. After measurement, the samples were transferred back to keep the same volume 
of the water for dye release.  
The steps followed to encapsulate the dye solution in the gold shell colloidosomes were the 
same as above. The only difference was that the waste oil phase was removed and the 
colloidosomes containing Allura Red AC dye were redispersed in HAuCl4 solution, with 
subsequent addition of the L-ascorbic acid solution and SDS solution, to form the gold shell. 
All the other capsule preparation steps are the same as reported above.  
2.2.6 Sample characterization 
The colloidosomes were imaged by scanning electron microscopy (SEM). A Zeiss X-beam 
FIB SEM was used at an accelerating voltage of 5.0 kV. The same instrument was used for 
energy-dispersive X-ray spectroscopy (EDX), to determine the elemental composition of the 
colloidosomes. In this case an accelerating voltage of 10.0 kV was used. A drop of particle 
suspension was air-dried on a stainless steel SEM stub overnight. The particulate polymer 
shell colloidosomes samples were then gold-coated using a BioRad SEM coating system 
sputter coater, in an argon environment at 1 × 10-3 mbar and 10 mA for 180 s. The silver and 
gold coated colloidosome samples were imaged without any treatment.  
The colloidosomes were also imaged by transmission electron microscopy (TEM). An FEI 
Philips Tecnai 20 TEM was used at 200 kV (Tungsten, LB6) high-energy electron beam. A 
drop of colloidosome sample was added onto a TEM grid and then transferred to the 
specimen holder.  
A UV-Vis spectrophotometer equipped with a tungsten lamp (Thermo Scientific, model 




characterized by spectrophotometry in 10 mm path length polystyrene cuvettes. The 
absorbance value at 500 nm was recorded using ultra-pure water as the reference.  
Confocal laser scanning microscopy (CLSM) images were captured with a Leica TS 
confocal scanning system (Leica, Germany) equipped with a 63×/1.4 oil immersion 
objective at an excitation wavelength of 480 nm and emission wavelength of 500-650 nm. 
Fluorescent images were also captured with a Nikon EFD-3 fluorescence microscope by a 
flourescein isothiocyanate filter. 
 
2.3 Results and discussion 
2.3.1 Silver coated colloidosome optimization 
In this section, we present how we found the optimized reaction conditions of silver 
coated colloidosomes. To make silver shells, a common and easy method is to prepare 
silver particles using chemical reduction, since the experimental conditions of this 
method are simple and the reaction time of AgNO3 is relatively short. Various 
experimental parameters were explored and optimized in this part. Table 2.1 shows 
different reaction conditions of silver shell for optimization.  
 
Optimization conditions Reaction conditions 
Reducing agent Na3Citrate, L-ascorbic acid 
Concentration of AgNO3 solution 0.1 wt%, 0.25 wt %, 0.5 wt%, 1.0 wt% 
Concentration of L-ascorbic acid solution 5 wt%, 10 wt%, 15 wt % 
Placement of reactants 
Make L-ascorbic acid-core colloidosome first, 
then add AgNO3 to form silver shells 
Make water-core colloidosome first, then add 
AgNO3 and L-ascorbic acid to form silver shells 
Reducing agent. We chose Na3Citrate and L-ascorbic acid as reducing agents. These are 
commonly used for reducing metals, such as silver and gold. Initially, we used one 
reducing agent in the core of colloidosome, then added AgNO3 solution. The aim of 




this design is to force the reaction to happen on the surface of the polymer shells, 
since the inner phase reducing agent will diffuse from the polymer shells and reach 
the outer phase AgNO3 solution (1.0 wt%). To make a reducing agent core for the 
particulate polymer shell colloidosomes, the latex particle suspension (11.2 wt%) was 
mixed with a reducing agent to get a mixture, which contained 5.6 wt% latex particles 
and a certain concentration of reducing agent. All the other capsule preparation steps 
are the same as reported in section 2.2.2. 
When using Na3Citrate (20 wt%) as a reducing agent at 60 °C, there was no obvious silver 
forming reaction, as shown in Fig. 2.8a. A high temperature is required when using 
Na3Citrate to form silver particles. Alternatively, we used AgNO3 solution in the core and 
Na3Citrate in the wash solution to form silver shells, using the same experimental conditions, 
but there was still no obvious silver forming reaction. When using L-ascorbic acid (15 wt%) 
as a reducing agent, there were some silver particles forming either in the solution or on the 
polymer shells, as shown in Fig. 2.8b. We also used AgNO3 solution in the core and L-
ascorbic acid in the wash solution to form silver shells, using the same experimental 
conditions, but there were very few silver particles forming even after 1 h, as shown in Fig. 
2.8c.  
Fig. 2.8 Experimental phenomenon when using (a) Na3Citrate, and (b) L-ascorbic acid as reduction 
agents in the core of particulate polymer shell to form silver shells, and (c) when using AgNO3 




Fig. 2.9 shows the SEM and EDX images of the silver shell colloidosome sample, which 
was made with L-ascorbic acid as the reducing agent in the core of the polymer shells. As 
can be seen, part of the particulate polymer shells was covered by silver particles, while 
there were also some broken polymer shells. As shown in Fig. 2.9b, the large silver peaks 
suggest silver particles are surrounding the colloidosome surface. The carbon peak arises 
from the particulate polymer shell, and the aluminium peak arises from the SEM stub. Based 
on this result, we chose L-ascorbic acid as the reducing agent for further optimization. 
Concentration of AgNO3 solution. In this section, the concentration of AgNO3 solution 
was varied: 0.1 wt%, 0.25 wt %, 0.5 wt%, and 1.0 wt%. We did not use too low concentration 
of the AgNO3 solution, only to 0.1 wt%, considering the silver shell formation. All 
particulate polymer shell colloidosomes were made with a 10.0 wt% L-ascorbic acid-
core, and the reaction kept at room temperature for 1 h. Fig. 2.10 shows the SEM 
images of the silver shell colloidosomes using different concentrations of AgNO3 
solution. It can be seen in Fig. 2.10a that silver coated colloidosomes were found. The silver 
particles grow on the surface of the polymer shells to form silver shells, and they were 
Fig. 2.9 (a) SEM and (b) EDX images of the silver shell colloidosomes sample, which was made by 




homogenous at a concentration of 0.1 wt%. As the concentration of AgNO3 solution 
progressed to 0.25 wt%, the silver shells were still to be found, but some line-like silver 
particles grew as well. Once the concentration of AgNO3 solution reached 0.5 wt% and 1.0 
wt%, as shown in Fig. 2.10c and d respectively, the sizes of the silver coated colloidosomes 
were uneven, and there were some line-like silver particles and broken polymer shells 
forming. So, based on this result, we chose 0.1 wt% AgNO3 solution for further optimization. 
Concentration of L-ascorbic acid solution. In this section, we made different 
concentrations of L-ascorbic acid-core particulate polymer shell colloidosomes: 5 
wt%, 10 wt %, and 15 wt%. Considering the solubility of L-ascorbic acid in water, 
we did not try a higher concentration. The concentration of AgNO3 solution was 0.1 wt%, 
and the reaction was kept at room temperature for 1 h. Fig. 2.11 shows the SEM 
images of the silver shell colloidosomes using different concentrations of L-ascorbic 
acid. When the concentration of L-ascorbic acid was 5 wt%, the silver coated colloidosomes 
were found and their morphology was spherical and homogenous. As the concentration of 
the L-ascorbic acid progressed to 10 wt% and 15 wt%, silver coated colloidosomes were 
still found with a larger size. In order to decide on a suitable concentration, we loaded the 
Fig. 2.10 SEM images of the silver shell colloidosomes using different concentrations of AgNO3 




Allura Red AC dye solution into the colloidosomes to see the permeability. The dye 
encapsulation steps are the same as reported in section 2.2.5. After loading dye solution and 
washing three times, we found the silver shell colloidosomes, which were produced using 5 
wt% and 10 wt% of L-ascorbic acid, leaked dye solution and 15 wt% ones did not. In 
addition, samples using 15 wt% L-ascorbic acid have a higher dye encapsulation efficiency. 
So, based on this result, we chose 15 wt% L-ascorbic acid solution for further optimization. 
The details about dye encapsulation and dye release are discussed in section 2.3.4.  
Placement of reactants. In this section, we made silver coated colloidosomes using 
different placement of reactants to see if we can improve the shell permeability and 
encapsulation efficiency of the colloidosomes. Initially, we made L-ascorbic acid-core 
colloidosomes, then added AgNO3 to form silver shells. Alternatively, we made water-core 
colloidosomes, then added L-ascorbic acid and AgNO3 to form the silver shell. In this 
experiment, the concentration of L-ascorbic acid was 15 wt%, and the concentration 
of AgNO3 solution was 0.1 wt%. Fig. 2.12 shows the SEM images of the silver shell 
colloidosomes made using these two methods. The morphology of the colloidosomes are 
similar. The particulate polymer shells are fully covered by silver particles with a sheet shape. 
The silver particles made from water-core colloidosome are thinner than the ones made from 
L-ascorbic acid-core colloidosome. Then we encapsulated the Allura Red AC dye solution 
in the colloidosomes to see the permeability of the two type of silver shells. The details about 
dye encapsulation and dye release will be discussed in section 2.3.4. After loading dye 
solution and releasing them by the addition of acid, we found that although both types of 
colloidosomes are impermeable, the silver shell colloidosomes which were produced using 
a water-core colloidosome first, have a higher encapsulation efficiency nearly twice that of 
Fig. 2.11 SEM images of the silver shell colloidosomes using different concentrations of L-ascorbic 




the ones produced using L-ascorbic acid. So, based on this result, we chose to make water-
core colloidosome first, then add AgNO3 and L-ascorbic acid to form the silver shell.  
Optimized reaction conditions. After optimization, we chose the following 
experimental conditions to make silver coated colloidosomes. Water-core particulate 
polymer shell colloidosomes were made first. 20 mL of the liquid colloidosome 
mixture was centrifuged, and the waste oil phase was removed via pipetting to get the 
particulate polymer shell colloidosome sediment. Then 24 mL of a 0.1 wt % aqueous 
solution of AgNO3 and 2 mL of a 1 wt% aqueous solution of SDS were added. 
Addition of 2 mL of a 15 wt% L-ascorbic acid aqueous solution started the silver 
reduction reaction, which was allowed to proceed for 1 h. SDS was used to avoid the  
aggregation of silver coated colloidosomes.  
Fig. 2.13a to d show the SEM, TEM, and EDX images of the silver coated 
colloidosomes produced with optimized conditions. As can be seen in Fig. 2.13a and 
b, the particulate polymer shells are fully covered by sheet-like silver particles, which 
form a film to improve the strength and impermeability of the colloidosomes. The 
silver coated colloidosome diameter is between 0.9 µm and 3.2 µm. The colloidosome 
sizes were measured using the software “Image J” based on the SEM images. For the 
TEM image, shown in Fig. 2.13c, the electrons cannot pass through the water core, 
and the edge of the silver particles sees a little melting, when using a high voltage of 
electrons. Fig. 2.13d shows the EDX image of the colloidosomes. The large silver 
peaks suggest that the silver particles are surrounding the colloidosome surface. The 
Fig. 2.12 SEM images of the silver shell colloidosomes reacting for different placement of reactants: 
(a) make L-ascorbic acid-core colloidosome first, then add AgNO3 to form silver shells, and (b) make 




strong carbon peak arises from the particulate polymer shell. The SEM stub is 
responsible for the aluminium peak and the other weak peaks arise from the surfactant. 
In addition, we used Allura Red AC-containing silver coated colloidosomes as a 
model. It can be seen from the fluorescent image in Fig. 2.13e that the dye solution 
can be successfully loaded on the surface of the colloidosomes or inside the 
colloidosomes. To test if the colloidosomes are impermeable or not, a dye release 
experiment was performed and discussed in section 2.3.4.  
2.3.2 Gold coated colloidosomes optimization 
In this section, we used the reduction method to prepare gold coated colloidosomes, 
which is similar to the silver shell system. Gold shells can be achieved by reducing 
HAuCl4 solution with a reducing agent. Based on the previous silver coated 
colloidosomes synthesis process, various experimental parameters for gold shells, 
Fig. 2.13 SEM, TEM, EDX and fluorescence microscope images of the silver coated colloidosomes 
produced with optimized conditions: (a) low magnification SEM image of silver coated colloidosomes, 
and (b) high magnification SEM image of a few gold coated colloidosome, (d) EDX image of silver 





including reducing agent and concentration of HAuCl4 solution, were explored and 
optimized. 
Reducing agent. Similar to the silver shell synthesis, we used Na3Citrate and L-
ascorbic acid as reducing agents. We chose Na3Citrate as our first choice, since this reducing 
method is commonly used for producing gold particles. Firstly, we made water-core 
colloidosomes, then added Na3Citrate and HAuCl4 at 60 °C to form the gold shell. A high 
temperature is required when using Na3Citrate to form gold particles. However, there 
were no gold shells forming, just some free gold particles in solution. Subsequently, 
we used 20 wt% Na3Citrate in the core of the particulate polymer shell colloidosomes, 
then added 0.5 wt% HAuCl4 solution at  60 °C to force the reaction to happen on the 
surface of the polymer shells. All the other colloidosome preparation steps are the 
same as reported in section 2.2.3. 
Fig. 2.14 SEM and EDX images of the gold coated colloidosomes, which were made using Na3Citrate 
in the core of the particulate polymer shells to form gold shells: (a) low magnification SEM image of 
a few gold coated colloidosomes, and (b)(c) high magnification SEM images of single gold coated 




Fig. 2.14 shows the SEM and EDX images of the gold coated colloidosomes, which 
were made using Na3Citrate in the core. It can be seen that the particulate polymer 
shell was covered with spherical gold nanoparticles. However, the gold particles just 
grew near the particulate polymer shells and did not form a film. The size of gold 
coated colloidosomes in Fig. 2.14b and c are about 1 µm and 1.3 µm. The size of the 
gold nanoparticles, which cover the polymer shells, is estimated at between 10 and 
70 nm. The particle sizes are measured by the software “Image J”. Fig. 2.14d shows 
the EDX image of the gold coated colloidosomes. The EDX result shows obvious 
gold peaks, which suggests that the nanoparticles surrounding the surface of the 
colloidosomes are gold. There is also a strong peak of carbon, which indicates that 
the polymer shell is under the gold. 
Alternatively, we used L-ascorbic acid as the reducing agent. We made water-core 
colloidosome first, then added L-ascorbic acid and HAuCl4 at room temperature to 
form a gold shell. In this experiment, the concentration of L-ascorbic acid was 15 
wt%, and the concentration of HAuCl4 solution was 0.5 wt%. All the other 
Fig. 2.15 SEM and EDX images of the gold coated colloidosomes, which were made using L-ascorbic 
acid in outer phase of particulate polymer shells to form gold shells: (a) low magnification, (b) high 




colloidosome preparation steps are the same as reported in section 2.2.3. Fig. 2.15 
shows the SEM images of the gold coated colloidosomes. As can be seen, most of the 
particulate polymer shells were fully covered by gold particles, while there were also heavily 
aggregated gold shells forming as shown in Fig. 2.15a. The EDX image in Fig. 2.15c shows 
obvious gold peaks, which suggests that the nanoparticles covering the surface of the 
polymer shells are gold. There is also a carbon peak and a weak oxygen peak, which arise 
from the polymer shells, and the SEM stub is responsible for the aluminium peak. Based on 
this result, we chose L-ascorbic acid as the reducing agent in the outer phase of particulate 
polymer shells to form gold shells for further optimization. 
Concentration of HAuCl4. In this section, different concentrations of HAuCl4 solution 
were used: 0.1 wt%, 0.5 wt%, and 1.0 wt%. Based on the silver shell synthesis, water-core 
particulate polymer shell colloidosomes were made first, and a certain concentration of 
HAuCl4 and 15.0 wt% L-ascorbic acid solution were added. The reaction was kept at room 
temperature for 1 h.  
Fig. 2.16 shows the SEM images of the gold coated colloidosomes, which were made using 
different concentrations of HAuCl4 to form gold shells. It can be seen in Fig. 2.16a that some 
gold coated colloidosomes were found, and there were still some uncoated polymer shells. 
This result suggests that the concentration is not high enough to form efficient gold shells. 
As the concentration of HAuCl4 solution increased to 0.5 wt%, more gold shells were found, 
but there were some aggregated gold shells forming as well. Once the concentration of 
HAuCl4 solution reached 1.0 wt%, the gold particles could homogenously grow on the 
surface of the polymer shells to form a gold shell without any aggregation, which is shown 
in Fig. 2.16c. Based on this result, we chose 0.1 wt% HAuCl4 solution for producing gold 
coated colloidosomes and a dye release experiment was carried out to measure the 
permeability of the gold shell, as reported in section 2.3.4.2.  
Fig. 2.16 SEM images of the gold coated colloidosomes, which were made using different concentration 




Optimized reaction conditions. After optimization, we chose the following 
experimental details to make gold coated colloidosomes. Water-core particulate 
polymer shell colloidosomes were made first. 20 mL of the liquid colloidosomes 
mixture was centrifuged and the waste oil phase was removed via pipetting to get the 
particulate polymer shell colloidosomes sediment. Then 20 mL of a 1.0 wt % aqueous 
solution of HAuCl4 and 2 mL of a 1 wt% aqueous solution of SDS were added. 
Addition of 2 mL of a 15 wt% L-ascorbic acid aqueous solution started the gold 
reduction reaction which lasted for 1 h. SDS was used to avoid the gold coated 
colloidosome aggregation.  
Fig. 2.17 shows the SEM, TEM and EDX images of the gold coated colloidosomes produced 
with optimized conditions. As can be seen in Fig. 2.17a to c, the particulate polymer shells 
are fully covered by gold particles to form gold shells, which can improve the strength and 
impermeability of the colloidosomes. The diameter of the gold coated colloidosomes is from 
about 0.8 µm to 2.1 µm. We planned to measure the thickness of the gold shells using 
TEM, but the electrons cannot pass through the colloidosomes as shown in Fig. 2.17d. 
The thickness of the gold shell of the colloidosomes is estimated to be around 50 nm. The 
thickness of the gold shell is calculated from the diameter of the polymer shell colloidosomes 
Fig. 2.17 SEM, TEM, and EDX images of the water core gold coated colloidosomes produced with 
optimized conditions: (a) (b) (c) different magnification SEM images of gold coated colloidosomes, (d) 




(0.7 µm to 2 µm) and the gold shell colloidosomes (0.8 µm to 2.1 µm). Fig. 2.17e shows the 
corresponding EDX image which has high gold peaks. This suggests that the particles 
surrounding the surface of the colloidosomes are gold. There is also a peak of carbon, arising 
from the particulate polymer shell. 
2.3.3 Release by ultrasonic treatment 
In order to release the metal capsules, we used an ultrasonic probe, which was operated at a 
frequency of 20 kHz and power output of 50 W to break the metal shell colloidosomes. For 
both silver and gold colloidosomes, we tried various sonication times.  
2.3.3.1 Silver coated colloidosomes  
A suspension of microcapsules was subjected to ultrasound sonication for different durations. 
Fig. 2.18 shows SEM images of silver shell colloidosomes after various sonication times. It 
can be seen that some of the capsules were broken into fragments after 120 s of treatment 
and most of the capsules were destroyed after 240 s.  
Fig. 2.18 SEM images of silver shell colloidosomes after various sonication times operating at a 




Fig. 2.19 shows CLSM images of dye-containing silver shell colloidosomes after various 
sonication times. The colloidosomes were dyed using Allura Red AC. It was seen that intact 
dye-containing silver shell colloidosomes were found without sonication. After 60 s and 120 
s of ultrasound treatment, there were some fluorescent dots appearing in the images. These 
may be either the dye solution attached on the surface of small broken silver shells or some 
released dye. After 120 s of ultrasound treatment, a significant number of the capsules were 
broken into fragments. For longer sonication times, more capsules were broken. After 240 s 
Fig. 2.19 CLSM images of dye-containing silver shell colloidosomes after various sonication times 
with λex =480 nm, fluorescent dye (left), bright field (right), and merged (middle) images. The 
ultrasound was operated at a frequency of 20 kHz and power output of 50 W after various sonication 




sonication, only a few colloidosomes survived and there were a large portion of small dots 
appearing in the CLSM images. These are likely to be small pieces of broken shell with dye 
attached on the surface or some released dye. 
2.3.3.2 Gold coated colloidosomes 
Fig. 2.20 shows SEM images of gold shell colloidosomes after various ultrasound sonication 
times also operating at a frequency of 20 kHz and power output of 50 W. As can be seen, 
some of the gold coated colloidosomes were broken into fragments after 240 s of treatment 
and most of the capsules were destroyed after 480 s. For longer sonication times, more 
capsules were broken. After 960 s sonication, only very few colloidosomes survived and 
there were a large number of small pieces of broken shell. Compared with the previous silver 
shells, the gold shells need longer ultrasound times for breaking. This may be the result of 
the different morphology and structure of the shells.  
  
Fig. 2.20 SEM images of gold shell colloidosomes after various ultrasound sonication times 





2.3.4 Dye encapsulation and dye release 
In order to test the permeability of the silver and gold coated colloidosomes, a hydrophilic 
dye Allura Red AC was encapsulated within the microcapsules to test the dye release, and 
the dyed water was characterized by spectrophotometry. This was carried out in a UV-Vis 
spectrophotometer, and the absorbance value at 500 nm was recorded.  
2.3.4.1 Silver coated colloidosomes  
Table 2.2 shows the calculation of the dye loss data and encapsulation efficiency of silver 
shells. As shown in the table, during manufacture, 17.5 % of the total dye was lost in the 
waste oil phase, which may contain the lost dye in sunflower oil and also a very small 
amount of dye leaking from the polymer shells after centrifugation. 59.8 % was lost in the 
washing solution during the silver forming reaction process. So the remaining dye 




Dye data Mass 






Dye added in the experiment 40.0 mg 100 % ---- ---- 
Dye measured in waste  oil phase  7.0 mg 17.5 % ---- ---- 
Dye measured in the washing solution 23.9 mg 59.8 % ---- ---- 
Dye remaining in the silver coated 
colloidosomes 
9.1 mg ---- 22.7 % ---- 
Dye released by the addition of acid 4.28 mg ---- ---- 47.0 % 
Dye released by ultrasound 0.77 mg ---- ---- 8.5 % 
This encapsulation efficiency was compared with other drug delivery materials or capsules. 
For examples, Vallet-Regí et al. [181] made mesoporous PLGA-SiO2 materials to load drugs 
in water, with a loading efficiency between 22.4% and 45.6%. Hitchcock et al. [65, 66] made 
an impermeable metal film around polymer microcapsules, which prevents loss of small 
volatile oils and has an encapsulation efficiency higher than 49 %. Keen et al. [10] made 
calcium carbonate coated colloidosomes encapsulating small molecules for several months 
Table 2.2 Calculation of the dye loss data and encapsulation efficiency of silver shells. All the dye 
data was measured three times to get an average result, and the standard error of the measurements 
were typically ±∼3%, which are not shown for clarity. All the dye absorbance data was measure in 




with an encapsulation efficiency of around 23%. For our samples, although the silver shell 
can change the permeability of the particulate polymer shells, we also decreased the 
encapsulation efficiency to a certain extent, which is lower than some drug delivery 
materials and capsules. It is also clear that further optimisation possibilities exist. 
Fig. 2.21 shows the release of Allura Red dye from colloidosomes. The samples were sealed 
with either a silver shell or a particulate polymer shell. Before measuring the dye release of 
silver coated colloidosomes, some blank tests were carried out to investigate if any chemical 
reactions exist between Allura Red dye, free-moving latex particles and silver particles. 
Three blank tests were: (1) Allura Red dye (28 mg) in ultra-pure water (20 mL); (2) Allura 
Red dye (28 mg) in ultra-pure water (18.6 mL) and latex particles (1.4 mL, 5.6 wt % particle 
suspension in ultra-pure water), which was stirred for 1 min; (3) Allura Red dye (28 mg) in 
Fig. 2.21 Release of Allura Red AC dye from blank dye, dye with free-moving latex particles, dye 
with free free-moving latex particles and silver particles, and dye encapsulated in polymer or silver 
shell colloidosomes. All the dye data was measured three times to get an average result, and the 
standard error of the measurements were typically ±∼3%, which are not shown for clarity. All the dye 




ultra-pure water (18.6 mL), latex particles (1.4 mL, 5.6 wt % particle suspension in ultra-
pure water) and free silver particles, which were produced by mixing L-Ascorbic acid and 
AgNO3 directly. The amount of silver in the control is the same as in the colloidosome 
synthesis procedure. The release data was normalized by the amount of encapsulated dye. 
This is the amount of dye added to the experiment minus the amount measured in the waste 
oil and washing solution. All mixtures were transferred into 10 cm of dialysis tubing and 
immersed in gently stirred ultra-pure water (450 mL). Fig. 2.21 illustrates the dye release 
profiles for the blank tests. It can be observed that all three control samples (samples 1, 2 
and 3) leaked dye solution without any trigger and have similar trends. The final release 
percentage of samples 2 and 3 was approximately 92%. For sample 1, the final release 
percentage was a little higher, around 96.5%. It should be noted that the free-moving latex 
or the dialysis tube may absorb a small amount of dye. Fig. 2.21 also illustrates the dye 
release profile for particulate polymer shell colloidosomes (sample 4). The release rate from 
particulate polymer shell colloidosomes was slower than unencapsulated material in dialysis 
tubing and the time to reach 50 % release was approximately 210 h. The final release 
percentage of sample 4 was approximately 78%. This is lower than the control samples and 
indicates that some dye may be absorbed onto the particulate polymer shells, either on the 
surface or remaining inside the polymer shells. 
The silver shell colloidosomes for this experiment were prepared by making the particulate 
polymer shell capsules first, then redispersing them in AgNO3 solution, and adding L-
Ascorbic acid. The calculation of the encapsulation efficiency and dye loss data are shown 
in Table 2.2. It can be seen that there was negligible dye outside the silver shell 
colloidosomes (sample 5). When 5 mL 1 wt% nitric acid was added, dissolving the shell 
(sample 6), the measured release yield was 47 %. It should be noted that the high temperature 
(65 °C) and nitric acid can destroy some of the dye, resulting in the lowering measured 
efficiency. We did a control experiment: 5mL 1 wt% nitric acid was added to the same 
amount and concentration of dye solution and heated at 65 °C for different durations. Then 
we tested the absorbance of the dye solutions using UV-Vis spectroscopy. After 10 min, 
there was about 20-30% loss. After 20 min, there was about half dye loss. With prolonged 
time, more dye was destroyed. After 30 min, there was nearly no dye remaining. 
When ultrasound treatment was used to break the silver shell colloidosomes (sample 7), a 




colloidosomes by ultrasound. For the particular situation in this study, the capsules were 
used at a rather high concentration so that the triggered dye solution reaches the sensitive 
zone of the UV-Vis. Therefore, the distance between the capsules and ultrasonicator probe 
has an effect on the resulting released amount. For future biological experiments (in vitro or 
for envisaged in vivo study), a low concentration of colloidosomes will be used in order to 
minimize their toxicity to normal cells or tissues. The release results demonstrate the 
complete sealing of the capsules and the dye release can be achieved using nitric acid or 
ultrasound. 











Dye added in the experiment 40.0 mg 100 % ---- ---- 
Dye measured in waste oil phase 7.0 mg 17.5 % ---- ---- 
Dye measured in the washing solution 26.7 mg 66.7 % ---- ---- 
Dye remaining in the gold coated 
colloidosomes 
6.3 mg ---- 15.8 % ---- 
Dye released by ultrasound 0.53 mg ---- ---- 8.4 % 
Table 2.3 shows the calculation of the dye loss data and encapsulation efficiency of gold 
shells. It can be seen form the table, during manufacture, 17.5 % of the total dye was lost in 
the waste oil phase, which may contain the lost dye in sunflower oil and also a very small 
amount of dye leaking from the polymer shells after centrifugation. 66.7 % was lost in the 
washing solution during the gold forming reaction process. So the encapsulation efficiency 
of the gold coated colloidosomes was about 15.8 %, which is lower than the silver coated 
colloidosomes. As discussed above in section 2.3.4.1, similar to the silver shells, although 
the gold shells can change the permeability of the particulate polymer shells, the 
encapsulation efficiency is lower than some drug delivery materials and capsules.  
Table 2.3 Calculation of the dye loss data and encapsulation efficiency of gold shells. All the dye 
data was measured three times to get an average result, and the standard error of the measurements 
were typically ±∼3%, which are not shown for clarity. All the dye absorbance data was measure in 




Fig. 2.22 shows the release profile of Allura Red AC dye from blank dye, dye with free-
moving latex particles, dye with free-moving latex particles and gold particles, and dye 
encapsulated in polymer or gold shell colloidosomes.  Similar to the release from silver shell 
capsules, some blank tests were carried out to investigate if any reactions exist between 
Allura Red dye, free-moving latex particles and gold particles. The release data was 
normalized by the amount of encapsulated dye in the capsules. It can be observed in Fig. 
2.22 that all three control samples (samples 1, 2 and 3) leaked dye without any trigger and 
have similar trends. The final release percentage of samples 2 and 3 were approximately 
95.4% and 94.3%, respectively. For sample 1, the final release percentage was a little higher, 
around 97.8%. It should be noted that the free-moving latex and the dialysis tube may absorb 
a small amount of dye.  
Fig. 2.22 Release of Allura Red AC dye from blank dye, dye with free-moving latex particles, dye 
with free-moving latex particles and gold particles, and dye encapsulated in polymer or gold shell 
colloidosomes. All the dye data was measured three times to get an average result, and the standard 
error of the measurements were typically ±∼3%, which are not shown for clarity. All the dye 




Fig. 2.22 also illustrates that the release rate from particulate polymer shell colloidosomes 
was slower than unencapsulated material in dialysis tubing, but the dye still leaked over 
about 500 h. The final release percentage of sample 4 was approximately 83.7%. This is 
lower than the blank control samples and indicates that some dye was possibly absorbed 
onto the particulate polymer shells, either on the surface or remaining inside the polymer 
shells. It can be seen that there was negligible dye released from the gold coated 
colloidosomes (sample 5) even after 900 h. When ultrasound treatment was used to break 
the capsules, the release occurred up to a maximum release yield of around 8.4%. Similar to 
the silver coated colloidosomes dye release, for this study, the gold shell capsules were also 
used at a rather high concentration. This means that the distance between the capsules and 
ultrasonicator probe has an effect on the amount of release. When the colloidosomes are too 
crowded, only the capsules near the ultrasonicator probe can be triggered. This is likely to 
be the reason for the relatively low apparent efficiency. These results indicate that the gold 
shell totally seals the encapsulated materials and the release of the dye in the gold shell can 
be triggered using ultrasound. It is also clear that further optimisation possibilities exist. 
 
2.4 Conclusions  
In this chapter, we present novel silver and gold coated colloidosomes, which are capable of 
small molecule encapsulation. The silver coated colloidosomes were prepared by making 
the particulate polymer shell first, then reacting L-Ascorbic acid with silver nitrate in the 
wash solution. The gold coated colloidosomes were prepared reacting L-Ascorbic acid with 
HAuCl4. The two types of colloidosome were successfully demonstrated to encapsulate 







Chapter 3.  
 
Targeting model - Immunoassay targeting 
 
The results from this chapter have been published in Langmuir and Soft Matter: 
Qian Sun, Yao Du, Ziyan Zhao, Elizabeth A. H. Hall, Hui Gao, Gleb B. Sukhorukov, 
Alexander F. Routh. Functional Silver-Coated Colloidosomes as Targeted Carriers for 
Small Molecules. Langmuir, 2017, 33(15): 3755-3764. 
Qian Sun, Yao Du, Elizabeth A. H. Hall, Dong Luo, Gleb B. Sukhorukov, Alexander F. 
Routh. A Fabrication Method of Gold Coated Colloidosomes and Their Application as 
Targeted Drug Carriers. Soft Matter, 2018, 14(14): 2594-2603. 
 
3.1 Introduction 
We plan to use the metal coated colloidosomes as targeted carriers for small molecular drugs. 
In general, targeting can be achieved by binding label specific cells or proteins with the 
capsules to find the targeted areas, or alternatively, using iron particles for magnetic 
positioning. Normally, fluorescent agents are used to follow the targeted tracking process. 
However, silver and gold particles quench fluorescent signals, especially gold particles. [182, 
183] So in this chapter, a label-free Surface Plasmon Resonance (SPR) biosensor was used to 
test the specific targeting.  
SPR biosensors are optical sensors exploiting electromagnetic waves to detect interactions 
between an analyte in solution and a biomolecular recognition element immobilized on the 
SPR sensor surface. [184] There are various measurement methods to monitor the binding 
event and then providing a measurable sensor response. For example, in a direct detection 
SPR immunoassay sensor, analyte in a sample can interact with a biomolecular recognition 




elements are antibodies. [184] Fig. 3.1 shows a schematic of a direct detection SPR 
immunoassay sensor, which shows a model of the interaction between antibody and analyte. 
[184] Since antibodies are the most frequently used biomolecular recognition element for SPR 
biosensors and it is quite simple to achieve, we chose to use antibodies and direct detection 
for our SPR design. 
In order to carry out the immunoassay reaction, we combined the specific antigens to the 
surface of our metal coated colloidosomes. Generally, to attach proteins on solid surfaces, 
there are two major methods: physical adsorption and chemical reaction linking. For 
physical adsorption, both the charge and surface area of the particles can affect the 
attachment of the proteins. [185] For chemical reaction linking, the small peptide region or 
the amino acid of proteins may bind with the surface of solids, usually with an irreversible 
structure change. When chemical linking happens, there will be some physical adsorption 
as well. [185, 186] For our experiment, in order to form a stable linking between metal shell 
capsules and the antigens, we chose to use a thiol chemical 4,4’-dithiodibutyric acid 
(including –SH and –COOH groups) to modify the surface of silver or gold shell, since it is 
easy to form an Ag-S or Au-S bond. [187, 188] Then the silver or gold shell colloidosome 
protein attachment is achieved through peptide coupling, which involves the activated 
carboxylic acid of 4,4’-dithiodibutyric acid and the N-terminal of the antigen. 
In this chapter, a specific targeting model - immunoassay targeting of the functional silver 
shell and gold shell colloidosomes with rabbit antigen is described. The metal coated 
colloidosomes attached with the rabbit Immunoglobulin G (Rabbit-IgG / rabbit antigen) can 
be captured by the anti-rabbit Immunoglobulin G (Anti-rabbit IgG / rabbit antibody) on the 
gold film of the SPR surface. We modified the capsule surface using 4,4’-dithiodibutyric 
Fig. 3.1 Schematic of a direct detection SPR immunoassay biosensor. (image reproduced from 




acid and attached with rabbit antigen (Rabbit-IgG). A label-free Surface Plasmon Resonance 
biosensor was used to test the specific targeting of the functional capsules with rabbit antigen. 
Then a custom-made flow cell channel built in the Analytical Biotechnology Group at 
Cambridge was used to perform targeted carrier experiments, and ultrasound treatment was 
used to break the shells attached onto the channels, as sketched in Fig. 3.6.   
 
3.2 Experimental section 
3.2.1 Materials 
The silver and gold coated colloidosomes were synthesized following sections 2.2.2 and 
2.2.3. Allura Red AC dye (Sigma-Aldrich), 4,4’-dithiodibutyric acid (DDA, 95%, Sigma-
Aldrich), N-hydroxysulfosuccinimide sodium salt (Sulfo-NHS, ≥ 98%, Sigma-Aldrich), N-
(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC, ≥ 98%, Sigma-
Aldrich) and phosphate buffered saline (PBS, Sigma-Aldrich) were used as received without 
purification. The vortex mixer was a TopMix FB15024 (Fisher Scientific). The water used 
in all experiments was deionized of resistivity 18.2 MΩ•cm produced by a Pure Lab Ultra 
apparatus. The StabilCoat® Immunoassay Stabilizer, rabbit Immunoglobulin G (Rabbit-
IgG), mouse Immunoglobulin G (Mouse-IgG) and anti-rabbit IgG produced in rabbits were 
purchased from Sigma-Aldrich.  
Fig. 3.2 shows the crystal structure of rabbit IgG [189], and the schematic of the specific rabbit 
antigen-antibody interaction. The schematic shows how the rabbit antigen induces the 
immune system response by interacting with the rabbit antibody which matches the antigens 






3.2.2 Attachment of Rabbit-IgG to silver and gold coated colloidosomes 
The reaction steps to attach Rabbit-IgG on silver coated colloidosomes is shown in Fig. 3.3. 
A known mass of silver or gold coated colloidosomes were dispersed in 0.5 wt% 4,4’-
dithiodibutyric acid (DDA) in ethanol solution using the vortex. The mixture was then gently 
mixed by a magnetic stirrer for 48 hours at room temperature [190]. After the reaction, the 
whole mixture was centrifuged at 1500 rpm for 2 min. The supernatant was removed using 
a pipette. The modified capsules were washed and redispersed three times using ultra-pure 
water.  
1 mL of modified silver or gold coated colloidosomes was transferred to an eppendorf tube. 
10 µL of N-hydroxysulfosuccinimide sodium salt (sulfo-NHS, 50 mg/mL) and 10 µL of N-
(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC, 50 mg/mL) were 
added to the eppendorf tube on the modified metal shell surface. The usage of sulfo-NHS 
Fig. 3.2 (a) The crystal structure of rabbit IgG. In this stereo representation of the structure, the two 
polypeptide chains are shown in green and blue, with their oligosaccharide chains (indicated as C 
and D) in yellow. The position of the N-termini on both chains is indicated by the letter N. The N-
terminal lower hinge region in each chain points directly towards the reader. (image reproduced from 




and EDC is to activate the carboxylic acid group of DDA. [190] Then the eppendorf tube was 
put on a rotator for 20 min. After rotating, the suspension was centrifuged at 2000 rpm for 2 
min at 25°C. The supernatant was removed via pipetting and the sediment was redispersed 
in PBS buffer solution using a vortex mixer. This washing process was repeated three times. 
After washing, 16.2 µL of Rabbit-IgG (12.35 mg/ml, rabbit antigen) was added into the 
colloidosome suspension such that the concentration of Rabbit-IgG in the suspension was 
200 µg/mL. The whole mixture was incubated with rotational mixing at 4ºC for 1 h and 
washed three times using PBS buffer solution. The silver or gold shell colloidosome protein 
attachment is achieved through peptide coupling which involves the activated carboxylic 
acid and the N-terminal of the protein. The modified colloidosomes were then stored at room 
temperature.  
3.2.3 SPR gold film crosslinking 
Fig. 3.4 shows the SPR gold film after combining with the rabbit antibody. A glass slide 
coated with a gold film of 50 nm thickness was washed with 70% ethanol and dried with 
nitrogen gas. 500 µL of DDA in pure water was introduced to the central part of the gold 
film and rested for 1 h. 10 µL of sulfo-NHS (50 mg/ml) and 10 µL of EDC (50 mg/ml) were 
added to the DDA solution in the central part of the gold film and left for 30 min. After 
resting, the gold film was washed with ultra-pure water and dried with nitrogen gas. This 
Fig. 3.3 Reaction steps to attach rabbit antigen (Rabbit-IgG) on silver coated colloidosomes surface. 
The whole surface of silver coated colloidosomes were attached with rabbit antigens, for clarity, only 




washing was repeated three times. Then 500 µL anti-rabbit IgG (200 µg/ml) was placed and 
confined to the central area of the gold film and left for 1 h at 4˚C. After resting, the gold 
film was washed with ultra-pure water and dried with nitrogen gas three times and stored in 
PBS solution at 4˚C.  
 
3.2.4 SPR experiment  
Fig. 3.5 SPR experimental flow chart using silver coated colloidosomes. 




A custom-made spectral Surface Plasmon Resonance biosensor setup in the Analytical 
Biotechnology Group was used to perform the immunoassay experiments. Before the 
measurements, the silver or gold shell colloidosomes were coated with rabbit antigens. In 
addition, the SPR gold film was immobilized with rabbit antibody. Fig. 3.5 shows the SPR 
experimental flow chart using silver coated colloidosomes as an example. Firstly, a known 
volume of the PBS solution was flowed into the cell for 10 min. After washing, the first data 
was recorded. Then a suspension of modified silver coated colloidosomes with rabbit 
antigen in PBS solution was injected using a syringe. After the SPR channel was filled with 
solution, the second data was recorded. Then the cell was rotated by 90° and kept in this 
horizontal position for 10 min to allow the silver shell capsules to settle onto the gold film. 
This also allows sufficient time for the binding between the antigen crosslinked with the 
silver shell and the antibody crosslinked with the gold film of SPR. After resting for 10 min, 
the third data was recorded and the cell was then rotated back to the vertical configuration. 
Finally, PBS solution was flowed into the cell for 10 min to wash away any unbound analyte. 
After washing, the fourth data was recorded. The reflectance spectrum is analyzed and the 
peak wavelength is recorded. 
3.2.5 Channel experiment 
Based on the SPR experiment results, a custom-made flow cell channel was built and the 
dye-containing silver or gold coated colloidosomes were used to perform targeted carrier 





experiments. Fig. 3.6 shows the experimental flow chart using dye-containing silver coated 
colloidosomes. A gold film, which was immobilized with rabbit antibody, was set up at the 
bottom of the channel. Firstly, a known volume of PBS solution was flowed into the cell 
channel. After washing, a suspension of dye-containing modified silver or gold coated 
colloidosomes crosslinked with rabbit antigen in PBS solution, was injected. After the 
channel was filled with the suspension, it was kept in this position for 10 min to allow the 
capsules to settle onto the gold film. After resting for 10 min, PBS solution was flowed into 
the channel to wash away any unbound analyte. Finally, the gold film crosslinked with dye-
containing colloidosomes was subjected to ultrasound to break the shells and release the dye. 
3.2.6 Sample characterization 
The silver and gold coated colloidosomes were imaged by SEM. The equipment was the 
same as described in section 2.2.6. An ultrasonic processor GEX 750 from Sonics & 
Materials Inc., USA was used to release the colloidosomes, operating at a frequency of 20 
kHz and power output of 50 W. The device is the same as reported in section 2.2.4. 
To analyse the colloidosomes before and after modification, a LabRAM HR Evolution 
Raman Spectroscopy (HORIBA Scientific) was applied. 
The Thermo Scientific NanoDrop ND-1000 spectrophotometer was used to measure the 
concentration of protein samples without dilution. The module displays the UV spectrum, 







3.3 Results and discussion 
3.3.1 Modification of silver and gold coated colloidosomes  
After making the silver coated colloidosomes, we used DDA to modify the surface of 
colloidosomes and redispersed the colloidosome samples in pure water. Fig. 3.7 shows the 
Raman spectrum for non-modified and DDA modified silver coated colloidosomes. It can 
be seen that the modified silver coated colloidosomes have an additional peak at 223 cm-1 
Raman shift. This is likely to correspond to an Ag-S bond [146], and it indicates the successful 
modification reaction between the silver shell colloidosomes and 4, 4’-dithiodibutyric acid 
as shown schematically in Fig. 3.8. In the modification reaction, the S-S structure of 4, 4’-
dithiodibutyric acid was broken, and the -SH group was combined with the surface of the 
silver coated colloidosomes. The Raman results suggest successful modification of the 
colloidosome surface.  
 
Fig. 3.8 Possible reaction between the silver shell surface and 4, 4’-dithiodibutyric acid. 




Similar to silver shells, we also used DDA to modify the gold coated colloidosomes and 
redispersed the gold shell colloidosome samples in pure water. The Raman spectrum 
showing the attachment of the gold shell to the sulfur of the DDA is shown by peaks at 370 
cm-1 in Fig. 3.9. [147] 
Both silver and gold shell colloidosomes for this experiment were modified by DDA solution 
and then combined with rabbit antigen. We used non-modified colloidosomes as a control 
experiment to see the loading efficiency. The concentration of the antigen solution was 
measured using a Nanodrop ND-1000 Spectrometer. After the antigen combination reaction, 
the average supernatant concentration for non-modified and modified samples were tested 
to calculate the loading efficiency. The loading efficiency of non-modified silver shell 
colloidosomes is about 5.5 µg/mg, and 7.4 µg/mg for DDA modified silver shell 
colloidosomes. The loading efficiency of non-modified gold shell colloidosomes is about 
4.2 µg/mg, and 6.6 µg/mg for DDA modified gold shell colloidosomes. One reasonable 
explanation is that the silver or gold shell can adsorb some antigens by physical adsorption 
[191, 192]. For modified samples, there existed both physical adsorption and chemical reactions. 
The chemical reaction can be demonstrated by the immunoassay SPR results. These two 
factors caused the lower antigen concentration of the supernatant.  
  




3.3.2 SPR targeting experiment  
3.3.2.1 Using silver coated colloidosomes 
Fig. 3.10 SPR reflectivity graphs of (a) (b) the rabbit antigen solution, (c) (d) non-modified silver 
shell colloidosomes, (e) (f) modified silver shell colloidosomes attached with rabbit antigen, and 




Fig. 3.10 shows SPR reflectivity graphs of the rabbit antigen solution, non-modified silver 
shell colloidosomes, modified silver shell colloidosomes attached with rabbit antigen, and 
modified silver shell colloidosomes attached with mouse antigen. Fig. 3.11 shows a bar chart 
of the SPR wavelength shift after 10 min settling and after washing. The resonance 
wavelength exhibits as a shift in the distribution demonstrating sensitivity to antigen and 
silver shell colloidosome deposition. Before measuring the reflectivity of modified samples, 
three blank tests were carried out to measure the quantitative red shift of the blank 
immunoassay reaction, and to investigate if any physical adsorption exists between the silver 
coated colloidosomes and the gold surface of SPR. The blank tests were: (i) rabbit antigen 
solution and (ii) non-modified silver shell colloidosomes, and (iii) modified silver shell 
colloidosomes attached with a mouse antigen. Fig. 3.10a and 3.10b illustrate that when 
injecting rabbit antigen solution, there was a 2.3 nm red shift even after washing. This was 
caused by the attachment of antigens, which were paired with the antibodies on the gold 
surface of SPR. Fig. 3.10c and 3.10d suggest that when injecting the non-modified silver 
shell colloidosomes, there was a 1.5 nm red shift at the ‘10 min’ position. However, after 
washing, the reflectivity graph came back to the original position and there was almost no 
red shift. It can be seen from Fig. 3.10 and 3.11 that the wavelength shift of non-modified 
samples was negligible. This indicates that there is no obvious physical adsorption between 
the silver coated colloidosomes and the gold surface. The red shift after 10 min of deposition 
can be simply explained by the settling of the colloidosomes onto the gold surface and they 




are easily washed away by the buffer solution.  
Fig 3.10e and 3.10f show SPR reflectivity graphs of modified silver shell colloidosomes 
attached with rabbit antigen. It is seen that there was a 2.1 nm red shift after washing. The 
capsules were attached on the gold film because of the specific binding between the antigen 
and antibody pair - the binding between the antigen combined with the silver shell and the 
antibody combined with the gold film of SPR. Fig. 3.10g and 3.10h show SPR reflectivity 
graphs of modified silver shell colloidosomes attached with a mouse antigen. There was no 
obvious red shift after washing, which suggests there is no specific binding between mouse 
antigen on the capsules and the rabbit antibody on the gold film.  
After the immunoassay experiments for the modified silver shell colloidosomes, we 
removed the SPR gold film and washed it a further three times. There were still many rabbit 
antigen modified silver shell colloidosomes on the gold film as shown in Fig. 3.12. Fig. 
3.12a is a low magnification of the gold film. Fig. 3.12b and 3.12c are different areas and 
different magnifications of the gold film. For the gold substrates, which were reacted to 
unmodified silver shell colloidosomes, and mouse antigen modified silver shell 
colloidosomes, there were only a few impurities and dust on the gold film surfaces with no 
silver shells. 
Fig. 3.12 SEM images of rabbit antigen modified silver shell colloidosomes which were combined 




3.3.2.2 Using gold coated colloidosomes 
Fig. 3.13 SPR reflectivity graphs of (a) (b) the rabbit antigen solution, (c) (d) non-modified gold 
shell colloidosomes, (e) (f) modified gold shell colloidosomes attached with rabbit antigen, and (g) 




Fig. 3.13 shows SPR reflectivity graphs for the rabbit antigen solution, non-modified gold 
shell colloidosomes, modified gold shell colloidosomes attached with rabbit antigen and 
modified gold shell colloidosomes attached with mouse antigen. Fig. 3.14 shows a bar chart 
of the SPR wavelength shift after 10 min settling and after washing. The experiment is the 
same as reported for silver shells. The results also show the attachment of gold shell capsules 
to the modified surface.  
The relatively large error bars in Fig. 3.14, across several repeat measurements are probably 
due to the low number of capsules captured by the gold film. As the capsules attach unevenly 
on the film, the interrogation zone under the light spot covers a different number of capsules 
resulting in a noticeable statistical variance. Nonetheless, the semi-quantitative SPR 
experiment shows that the gold shell capsules with antigens attached at the surface can 
combine with the surface of the gold film due to antibody-antigen interaction.  
Similar to silver shells, after the immunoassay experiments for the modified gold shell 
colloidosomes, the gold film was removed and washed a further three times. There were still 
many modified gold shell capsules on the gold film as shown in Fig. 3.15. For the gold 
substrate, which was reacted to unmodified and mouse antigen modified gold shell 
colloidosomes, there were only a few impurities and dust on the surface, with no gold shells. 
This result suggests that the gold coated colloidosomes can be combined with proteins after 





For both the silver and gold shell SPR experiments, we only achieved a low number of 
capsules captured on the gold film. Additionally, the capsules were attached unevenly on the 
film, and because the interrogation zone under the light spot covers a different number of 
capsules, there are relatively large error bars in the SPR wavelength shift bar chart and only 
a few nanometres red shift. In the literature, Lertvachirapaiboon et al. [159] reported a SPR 
peak shift for the antibody analyte of about 2-3 nm; then they tried to use the antibody-
nanogold binding analyte leading to an enhancement to about 7 nm SPR peak shift. In order 
to produce an improvement in sensitivity for small molecule detection based on SPR bio-
sensing, Hong et al. [-166] used gold nanoparticles on SPR surface to change the SPR 
resonance condition and cause the enhancement, resulting in a 7 nm wavelength shift from 
the classic gold SPR thin film. Consequently, more optimization should be explored for 
future research in order to achieve a more obvious SPR wavelength shift, and also, a higher 






Fig. 3.15 SEM images of the rabbit antigen modified gold shell colloidosomes which were combined 




3.3.3 Channel experiment  
3.3.3.1 Using silver coated colloidosomes 
A custom-made flow cell channel was used to perform targeted carriers experiments. A gold 
film, which was immobilized with anti-rabbit IgG, was set up at the bottom of the channel. 
After the experiment, the gold film coating with some dye-containing silver shell 
colloidosomes was subjected to ultrasound to break the shell and release the dye.  
Fig. 3.16 shows SEM images of the channel gold film after combining with dye-containing 
silver shell colloidosomes. One can observe a large number of dye-containing silver coated 
colloidosomes attached on the gold film after the immunoassay reaction. This attachment 
illustrates the possibility for silver coated colloidosomes to be used as targeted carriers. Fig. 
3.17 shows SEM images of the channel gold film combining with dye-containing silver shell 
colloidosomes after ultrasound treatment, operating at a frequency of 20 kHz and power 
output of 50 W. It can be seen that after 240 s of ultrasound the capsules attached on the gold 
film were destroyed into fragments with only very few capsules remaining intact. This 
Fig. 3.16 SEM images of the channel gold film after combining with the dye-containing silver shell 
colloidosomes. 
Fig. 3.17 SEM images of the channel gold film combining with dye-containing silver shell 
colloidosomes after ultrasound treatment. An ultrasonic probe, operating at a frequency of 20 kHz 




indicates that the silver shell colloidosomes are promising to be used as targeted carriers for 
small molecules which can be released by ultrasound. 
3.3.3.2 Using gold coated colloidosomes 
Fig. 3.18 shows SEM images of the gold film after combining with dye-containing gold 
shell colloidosomes. A large number of the dye-containing gold coated colloidosomes 
attached on the gold film can be seen. After 240 s of ultrasound the capsules were destroyed 
into fragments with only a few capsules remaining intact as shown in Fig. 3.19. Similar to 
silver shell colloidosomes, the gold shell colloidosomes perform well as targeted carriers 
which can be released by ultrasound. 
In this chapter, we used a label-free SPR biosensor and a custom-made channel to test the 
specific targeting of the functional capsules with rabbit antigen, in order to prove the antigen 
binding to colloidosomes. For future research, more characterization, can be explored to 
prove the protein binding to the metal coated colloidosome surface. For example, 
immunoelectron microscopy with antibodies is possible to test the binding proteins, in order 
to confirm the presence of the target antigens on the colloidosomes surface. [193] In addition, 
Fig. 3.18 SEM images of the channel gold film after combining with dye-containing gold shell 
colloidosomes. 
Fig. 3.19 SEM images of the channel gold film combining with dye-containing gold shell 
colloidosomes after ultrasound treatment. An ultrasonic probe, operating at a frequency of 20 kHz 




it is also possible to use neutron and X-ray reflectivity techniques to test the binding proteins. 
[194] It is possible to observe the different adsorbed protein layer by screening out the other 
layers through contrast matching by measuring the partial proton densities of the different 
components. Therefore, it is possible to study the antigen recognition at the surface of the 
colloidosomes using neutron reflectivity. [194] 
 
3.4 Conclusions  
In this chapter, we present silver and gold coated colloidosomes which are capable of 
immunoassay targeting and small molecule encapsulation. Both types of colloidosomes can 
be ruptured using ultrasound treatment, operating at a frequency of 20 kHz and power output 
of 50 W. The metal coated colloidosomes were modified using 4,4’-dithiodibutyric acid and 
then combined with rabbit antigen. The Surface Plasmon Resonance biosensor, which was 
used for an immunoassay sensitivity measurement, proved that the two types of functional 
colloidosomes combined with the rabbit antigen can be captured by the rabbit antibody, 
which was immobilized on a gold film surface of SPR. For the SPR experiment, in order to 
achieve a higher loading efficiency of the metal capsules attached on the gold film of SPR, 
more optimization should be explored for future research. In summary, the functional silver 
and gold coated colloidosomes are promising for many future medical applications, 
including targeted carriers for small bioactive molecules with controlled drug delivery and 






Chapter 4.  
 
Anticancer drug encapsulation - Doxorubicin 
 
The results from this chapter have been published in ACS Applied Materials & Interfaces 
and Soft Matter: 
Qian Sun, Hui Gao, Gleb B. Sukhorukov, Alexander F. Routh. Silver Coated Colloidosomes 
as Carriers for an Anticancer Drug. ACS Applied Materials & Interfaces, 2017, 9(38), 
32599-32606. 
Qian Sun, Yao Du, Elizabeth A. H. Hall, Dong Luo, Gleb B. Sukhorukov, Alexander F. 
Routh, A Fabrication Method of Gold Coated Colloidosomes and Their Application as 
Targeted Drug Carriers. Soft Matter, 2018, 14(14): 2594-2603. 
 
4.1 Introduction 
Small drug molecules play an important role in medical applications and are widely used in 
the pharmaceutical industry. Microcapsules have been developed and used to deliver such 
drugs to targeted areas. [93-98] The encapsulation of small molecules within particulate 
polymer shells still presents a significant challenge, since most particulate polymer shells 
tend to leak small molecules, due to their intrinsic high permeability. This greatly limits their 
practical application. To solve this problem, we describe a method for encapsulating an 
anticancer drug, doxorubicin, using both silver and gold coated colloidosomes. Doxorubicin 
hydrochloride (DOX) is a well-known anticancer drug which has been proven effective 
against various human malignancies, including various types of cancers. [195] In this chapter, 
we used doxorubicin hydrochloride as an example for drug encapsulation. Both the silver 
and gold coated colloidosomes can be triggered using a 50 W ultrasound and high intensity 




cancer cells was used to test cell viability. We tested a few control samples, including water 
core silver or gold shell colloidosomes with and without ultrasound, and doxorubicin-
containing silver or gold shell colloidosomes with and without ultrasound to test the toxicity 
of the capsules.  
 
4.2 Experimental section 
4.2.1 Materials 
The base particulate polymer shell, silver shell and gold shell colloidosomes were made in 
exactly the same process as reported in sections 2.2.1, 2.2.2 and 2.2.3. The other chemicals 
used in the experiments were sodium dodecyl sulfate (SDS, Fisher Scientific), Allura Red 
AC dye (Sigma-Aldrich), buffer solution pH 10.0 (Sigma-Aldrich), 4,4’-dithiodibutyric acid 
(DDA, 95%, Sigma-Aldrich), and doxorubicin hydrochloride anticancer drug (98.0%, 
Sigma-Aldrich). They were all used as received without purification. The reason we used 
doxorubicin hydrochloride as a drug model is that this drug is commonly used for 
cancer research studies and does not affect the colloidosome synthesis process.  It is 
small enough to diffuse from the porous particulate polymer shells. Fig. 4.1 shows 
the chemical structure of doxorubicin hydrochloride (DOX). 
For cell culture and viability studies, the materials used were Dulbecco’s modified eagles 
media (DMEM), fetal bovine serum (FBS), penicillin, streptomycin, trypsin, thiazolyl blue 
tetrazolium bromide (MTT), and dimethyl sulfoxide (DMSO). These were all supplied by 




Sigma-Aldrich. Ultrapure deionised water, of resistivity 18.2 MΩ•cm, was produced by a 
Pure Lab Ultra apparatus. For mixing, a TopMix FB15024 vortex mixer (Fisher Scientific) 
was used.  
4.2.2 Doxorubicin encapsulation 
In this chapter, we used both silver and gold coated colloidosomes to encapsulate the 
anticancer drug doxorubicin. Fig. 4.2 shows schematically how doxorubicin-
containing silver coated colloidosomes were formed. A Silverson high shear mixer 
(model SL2) was used to mix 200 mL sunflower oil and 4 mL of Span 80 in a 400 
mL beaker. A separate aqueous phase containing 5.6 wt% latex particles and 2 mg/mL 
doxorubicin hydrochloride in a pH 10 buffer solution was made, and 2 mL of this 
aqueous phase was added into the sunflower oil, whilst applying shear. Five cycles of 
mixing and rest were applied, where shear was applied for 60 s, followed by 30 s rest. 
As mentioned in section 2.2.3, this cyclic process enabled the emulsion droplets 
which were more uniform and smaller to form. 
To form the particulate polymer shells the emulsion mixture was heated in a water 
bath. To ensure rapid heat transfer, the emulsion mixture was split into five different 
tubes and when the temperature reached 50 ± 0.5°C, the emulsions were heated for 1 
h. To clean the capsules, 20 mL of the solution was centrifuged at 20°C and 2500 rpm 
for 10 min. After removing the waste oil phase together with the small amount of drug 
solution which had leaked from the colloidosomes, 24 mL of a 0.1 wt % aqueous solution 




of AgNO3 and 2 mL of a 1 wt% aqueous solution of SDS were added and the mixture 
was agitated using the vortex mixer. Addition of 2 mL of a 15 wt% L-ascorbic acid 
aqueous solution started the silver formation which was allowed to proceed for 1 h. 
In this reaction, L-ascorbic acid is a reducing agent, which reduces silver ions into 
silver particles. To obtain the final aqueous dispersion of doxorubicin-containing 
silver coated microcapsules, the mixture was centrifuged, at 20°C and 1500 rpm for 
2 min followed by redispersal in a 0.1 wt% SDS solution, used to avoid colloidosome 
aggregation. 
The steps followed to encapsulate the drug using gold coated colloidosomes were 
similar with the silver ones as above; the only difference is using 20 mL of 1 wt% 
aqueous solution of HAuCl4 and 2 mL of 15 wt% aqueous solution of L-ascorbic acid 
to form a gold shell.  
To disperse the capsules in pure water, a surface modification with 4,4’-
dithiodibutyric acid (DDA) was carried out as described in section 3.2.2. A 20 mL 
solution of 0.5 wt% 4,4’-dithiodibutyric acid (DDA) in ethanol was mixed using the 
vortex and a known mass of silver or gold coated colloidosomes was added. Mixing 
by a magnetic stirrer for 48 h at room temperature allowed the reaction to proceed, 
after which the modified capsules were cleaned by three cycles of centrifuging at 
1500 rpm for 2 min followed by re-dispersal in ultrapure water. 
4.2.3 Release by ultrasonic treatment  
An ultrasonic processor GEX 750 from Sonics & Materials Inc., USA was used to 
break the metal shell capsules. The method details and the ultrasound device are the 
same as reported in section 2.2.4. An ultrasonic probe, operating at a frequency of 20 
kHz and power output of 50 W was used. The temperature change was kept below 
5°C by using an ice bath. 
In addition, we also tried high intensity focused ultrasound (HIFU) to break the metal 
shell capsules. Fig. 4.3 shows a schematic of a home-made high intensity focused 
ultrasound device, which is provided by Prof Gleb Sukhorukov at Queen Mary, 
University of London. This set-up produces ultrasound with a frequency of 2.65MHz 




capsules, glass slides (1cm×1cm) were incubated in the PEI solution (2mg/mL, 0.5 
M NaCl) for 30 min to coat them with PEI, and then washed three times with pure 
water. The metal shell microcapsules were dropped onto the glass slide and dried in 
air for further HIFU treatment. The slide was held with a tweezer and was located it 
the central area of HIFU and kept for a certain time. Finally, the slide was attached 
onto the SEM sample holder to measure the SEM images. 
4.2.4 Cell culture and cell viability test 
The cell viability tests were carried out by Hui Gao, Dong Luo and Prof Gleb 
Sukhorukov at Queen Mary, University of London. Cell viability was assessed via a 
standard MTT assay and examined by a BMG Fluostar Galaxy plate reader. Rat 
neuroblastoma B50 cells were cultured in DMEM supplemented with 10% FBS and 
penicillin-streptomycin (1%) containing 5% CO2/95% air at 37°C. For cell viability 
studies, B50 cells were plated at 20 000 cells per well on 96 well plates. The next day 
microcapsules with different compositions and with or without ultrasonication, were 
added at ratios of 10, 20, or 50 capsules per cell to triplicate wells. The experiment 
was terminated when the total incubation times reached either 24, 48, or 72 h. Then 
a 100 μL thiazolyl blue tetrazolium bromide (MTT) solution (5 mg/mL in cell culture 
medium) was added to each well, and the plates were briefly shaken and then 
incubated for 3 h before dimethyl sulfoxide (DMSO) was added. Finally, cell viability 
Fig. 4.3 Schematic of home-made high intensity focused ultrasound device, which is provided by 




after coculturing with capsules for 24-72 h was assessed and read by a Multiskan 
Ascent plate reader. It is worth mentioning that a hemocytometer (a counting chamber) 
was used for determining the number of cells or microcapsules per unit volume of a 
suspension. The original cell and microcapsule suspensions were diluted low enough 
for counting on a hemocytometer under optical microscopy, and the concentrations 
of these original suspensions were calculated based on the dilution factor and the 
obtained number of cells or capsules per unit volume.  
4.2.5 Sample characterization 
The colloidosomes were characterised using SEM and CLSM. The method details 
and equipment were the same as described in section 2.2.6.  
To test the drug encapsulation efficiency, a UV-Vis spectrophotometer equipped with a 
tungsten lamp (Thermo Scientific, model Heλios Gamma) was used for spectrometry 
measurements. The fluorescent doxorubicin was characterized by spectrophotometry in 10 





4.3 Results and discussion 
4.3.1 Doxorubicin encapsulation 
4.3.1.1 Using silver coated colloidosomes  
Fig. 4.4 shows SEM images of doxorubicin-containing silver coated colloidosomes. 
It can be seen that the particulate polymer shells are fully covered by sheet-like silver 
particles. The morphology of the silver shells doesn’t change noticeably with 
doxorubicin encapsulation, compared with the water-core silver colloidosomes in Fig. 
2.13. These capsules were then modified using DDA to disperse the drug-containing 
silver shell capsules in pure water, ready for cell viability tests.  
The amount of fluorescent doxorubicin can be measured by a UV-Vis 
spectrophotometer. The calculation of the silver shell capsules drug loss data and 
encapsulation efficiency is shown in Table 4.1. During manufacture, 27.75 % of the 
total drug was lost in the waste oil phase, which may contain the lost drug in 
sunflower oil, and also, a small amount of drug which had leaked from the polymer 
shells after centrifugation. 49.75 % was lost in the washing solution. So, the 
remaining drug in the silver coated colloidosomes was about 22.50 %, which was the 
drug encapsulation efficiency.  
 
 
Fig. 4.4 SEM images of doxorubicin-containing silver coated colloidosomes: (a) low magnification, 







4.3.1.2 Using gold coated colloidosomes 
Fig. 4.5 shows SEM images of doxorubicin-containing gold coated colloidosomes. It 
can be seen that the particulate polymer shells are fully covered by gold particles. The 
morphology of the gold shells doesn’t change noticeably and are still spherical with 
doxorubicin encapsulation, compared with the water-core gold coated colloidosomes 
in Fig. 2.17. These capsules were also modified using DDA for dispersing in pure 
water, ready for cell viability tests. 
The calculation of the gold shell capsules drug loss data and encapsulation efficiency 
is shown in Table 4.2. During manufacture, 27.75 % of the total drug was lost in the 
waste oil phase. 56.25 % was lost in the washing solution. So the remaining drug in 
Drug data Mass 




Amount of drug added in the experiment 4.0 mg 100 % ---- 
Amount measured in the  waste oil  phase 1.11 mg 27.75 % ---- 
Amount measured in the washing solution 1.99 mg 49.75 % ---- 
Amount remaining drug in the silver shells  0.90 mg ---- 22.50 % 
Fig. 4.5 SEM images of doxorubicin-containing gold coated colloidosomes: (a) low magnification, 
and (b) high magnification. 
Table 4.1 Calculation of the drug loss data and encapsulation efficiency of silver shells. All the drug 
data was measured three times to get an average result, and the standard error of the measurements 
were typically ±∼3%, which are not shown for clarity. All the drug absorbance data was measure in 




the gold coated colloidosomes was about 16.0 %. This result suggests the gold coated 
colloidosomes have a lower drug loading efficiency compared with 22.50 % of silver 







Drug data Mass 




Amount of drug added in the experiment 4.0 mg 100 % ---- 
Amount measured in the waste  oil phase 1.11 mg 27.75 % ---- 
Amount measured in the washing solution 2.25 mg 56.25 % ---- 
Amount remaining in the gold shells 0.64 mg ---- 16.0 % 
Table 4.2 Calculation of the drug loss data and encapsulation efficiency of gold shells. All the drug 
data was measured three times to get an average result, and the standard error of the measurements 
were typically ±∼3%, which are not shown for clarity. All the drug absorbance data was measure in 




4.3.2 Release by ultrasonic treatment 
4.3.2.1 Silver coated colloidosomes  
Using ultrasound probe. Fig 4.6 shows SEM images of doxorubicin-containing 
colloidosomes with a silver shell before and after 120 s of ultrasound treatment. Fig. 4.7 
shows CLSM images of the same silver coated capsules before and after ultrasound 
treatment. An ultrasonic probe, operating at a frequency of 20 kHz and power output of 50 
W was used for 120 s. 
After 120 s of ultrasound treatment, the silver shell capsules were seen to be broken into 
fragments and most of the capsules were destroyed. There were a large number of small dots 
appearing in the CLSM images in Fig. 4.7, which are likely to be the small pieces of broken 
shell, and some doxorubicin which was attched to the small broken shells. To see if there 
was any released doxorubicin, a futher cell viability experiment was  performed.  
 
 
Fig. 4.6 SEM images of doxorubicin-containing silver coated colloidosomes before and after 
ultrasound treatment: (a) (b (c) without ultrasound treatment, and (d) (e) (f) after 120 s of ultrasound 
treatment. An ultrasonic probe, operating at a frequency of 20 kHz and power output of 50 W was 




Fig. 4.8 shows CLSM images of the surface of some doxorubicin-containing silver coated 
capsules. When focusing onto the surface of these capsules, there was also some fluorescent 
doxorubicin appearing, which cannot be easily washed off. This indicates that the drug was 
not only sealed in the silver shells, but some was also attached on the surface of the capsules. 
The possible reason is that during the formation of silver shells, the doxorubicin which is 
sealed inside the polymer shell may diffuse from the  polymer shells and may attach onto 
the surface of the silver shells.  
Fig. 4.7 CLSM images of doxorubicin-containing silver coated colloidosomes before and after 120 s 
of ultrasound treatment, with λex =480 nm, fluorescent drug (left), bright field (right), and merged 
(middle) images. The ultrasound was operated at a frequency of 20 kHz and power output of 50 W for 
120 s: (a) without ultrasound treatment, and (b) after 120 s of ultrasound treatment. 
Fig. 4.8 CLSM images of the surface of some doxorubicin-containing silver coated colloidosomes 




Using HIFU. For the ultrasound treatment with a high power of 50 W, a few minutes 
is enough to break most of the silver coated colloidosomes and release the drug 
solution. However, considering the application, we also tried high intensity focused 
ultrasound (HIFU) with a frequency of 2.65 MHz and a power of 6 W, which can be 
used for some cancer treatments. Fig. 4.9 shows SEM images of the doxorubicin-
containing silver shell colloidosomes before and after 120 s of HIFU treatment. It is 
clearly seen that part of the silver shells were deformed and broken after exposure to 
HIFU, however, there were still a large number of intact colloidosomes. This may be 
caused by the lower power of the ultrasound, where a relatively long duration time is 
needed to damage the silver coated colloidosomes.  
4.3.2.2 Gold coated colloidosomes 
Using ultrasound probe. Fig. 4.10 shows SEM images of doxorubicin-containing gold 
coated colloidosomes and the same capsule samples after 240 s of ultrasound 
treatment, operating at a frequency of 20 kHz and power output of 50 W. As we can 
see, after 240 s of ultrasound treatment, most of the doxorubicin-containing gold 
coated colloidosomes were broken into small fragments. We also tried to use CLSM 
to take some fluorescent images to test the doxorubicin attached in or on gold shell 
capsules. However, since the gold shells quench fluorescent signal, no fluorescent 
Fig. 4.9 SEM images of doxorubicin-containing silver coated colloidosomes before and after 120 s of 





images were obtained.  
Using HIFU. For the ultrasound treatment with a high power of 50 W, a few minutes 
is enough to break most of the gold coated colloidosomes and release the drug 
solution. Here, we also tried high intensity focused ultrasound (HIFU) with a 
frequency of 2.65 MHz and a power of 6 W to break the gold coated colloidosomes. 
Fig. 4.11 shows the SEM images of doxorubicin-containing gold shell colloidosomes 
after 120 s of HIFU treatment. It is clearly seen that part of the gold shells were 
deformed and broken. But there were still a large number of intact colloidosomes. 
Fig. 4.11 SEM images of doxorubicin-containing gold coated colloidosomes before and after 120 s of 
HIFU ultrasound treatment, with a frequency of 2.65MHz and a power of 6 W. (a)-(d) showing 
different magnifications. 
Fig. 4.10 SEM images of doxorubicin-containing gold coated colloidosomes before and after ultrasound 
treatment: (a) without ultrasound treatment, and (b) after 240 s of ultrasound treatment. An ultrasonic 




In this part, we used two types of ultrasound treatment to break both the doxorubicin-
containing silver and gold coated colloidosomes. For the high power (50 W) 
ultrasound probe, it is possible to break most of the metal coated colloidosomes and 
release the drugs. When using a HIFU treatment for a few minutes, part of the metal 
shells was deformed and broken, and there was still a large percentage of metal shell 
colloidosomes intact. In order to use HIFU treatment to break capsules, further 






4.3.3 Cell viability test  
4.3.3.1 Using silver coated colloidosomes 
A cytotoxicity study was carried out in vitro at different capsules/cell concentrations 
for B50 cancer cells for up to 72 h. Fig. 4.12 shows the viability of the B50 cells when 
mixed with different amounts of particulate polymer shell colloidosomes, free 
doxorubicin, silver shell colloidosomes, silver shell colloidosomes after 120 s 
ultrasound, doxorubicin-containing silver shell colloidosomes and doxorubicin-
containing silver shell colloidosomes after 120 s ultrasound. The experiments were 
carried out for (a) 24 h, (b) 48 h, and (c) 72 h at 37 °C, and measured by an MTT 
assay relative to the control. To break the silver shells, ultrasound was used for 120 s 
at a frequency of 20 kHz and power output of 50 W, before adding into the B50 cells.  
Fig. 4.12 Viability of B50 cells mixed with different amounts of particulate polymer shell 
colloidosomes, free doxorubicin, silver shell colloidosomes, silver shell colloidosomes after 120 s 
ultrasound, doxorubicin-containing silver shell colloidosomes and doxorubicin-containing silver shell 
colloidosomes after 120 s ultrasound. (a) 24 h, (b) 48 h, and (c) 72 h at 37 °C. The error bars show the 
standard deviations. The ultrasound treatment was operated at a frequency of 20 kHz and power output 




Cells are very sensitive to the external particles, hence, the concentration of the 
introduced particles is a key factor that determines their cell toxicity. Usually, higher 
the concentration of the drug carriers, the lower the cell viability is. In this study, we 
set up the capsule/cell ratio at 10, 20 and 50 to investigate the cell viability. 50 
capsules/cell showed relative high cell toxicity, therefore ratios higher than 50 were 
not carried out. On the contrary, the data demonstrated a very low cytotoxicity at 10 
capsules/cell, so we did not try a lower concentration. When prolonging the 
incubation time, more cells might be affected by the introduction of external capsules. 
For controlled instant release of drugs, capsules can be up taken by cells within 6 
hours, and then triggered by external stimuli, i.e., ultrasound, hence a good 
biocompatibility within 48 hours is enough to secure the delivery of encapsulated 
cargoes by colloidosomes to the targeted area. In addition, a higher concentration of 
capsules means a higher amount of drugs that can be delivered. 
As seen in Fig. 4.12, for 10 capsules/cell, both the particulate polymer shells and free 
doxorubicin show low toxicity to the cancer cells with a cell viability more than 95% 
from 24 h to 72 h. The results of silver shells indicate low cytotoxicity, in Fig. 4.12a, 
showing the cell viability at more than 90% during the first 24 h and in Fig. 4.12b 
more than 80% after 48 h. After 72 h, in Fig. 4.12c, the cell viability of silver shells 
dropped to around 60%, indicating an increased toxicity to cells when prolonging the 
incubation time. After ultrasound treatment, the broken silver shells display a 
relatively high cytotoxicity with a cell viability of around 50% during the first 48 h 
and around 40% after 72 h. The possible reason is that after ultrasound the pieces of 
broken shell are smaller compared with intact capsules, which become more toxic to 
living cells [196-199]. The doxorubicin-containing silver shell colloidosomes also lead 
to a low cell viability, showing around 20% after 72 h in Fig. 4.12c. A possible reason 
for this is that when making the silver shell colloidosomes, the drug may diffuse 
through the particulate polymer shell and may attach on the surface of the silver shells. 
Even after three washing processes, the attached drug seems to not be easily washed 
off. The doxorubicin on the surface may then be toxic to the cancer cells, leading to 
the decreased cell viability. The doxorubicin-containing silver shells after 120 s of 
ultrasound treatment illustrate a higher cytotoxicity, displaying a viability of about 
15% after 72 h. This is because of the released drug, the broken silver shells and the 




capsules/cell, the free doxorubicin at this concentration is not high enough to kill too 
many cells; when increasing the concentration, the effect was more obvious.  
The cell viability tests of 20 capsules/cell display a similar trend. Both the particulate 
polymer shells and free doxorubicin show low toxicity to cancer cells. However, the 
silver shell results indicate a higher cytotoxicity compared with particulate polymer 
shells, in Fig. 4.12b, showing the cell viability at about 60% during the first 48 h. 
After 72 h, in Fig 4.12c, the cell viability of silver shells dropped to around 50%. 
After ultrasound treatment, the broken silver shells display a relatively high 
cytotoxicity, showing a cell viability of around 40% during the first 48 h and lower 
than 30% after 72 h. The doxorubicin-containing silver shell colloidosomes also lead 
to a low cell viability, showing around 20% after 72 h in Fig. 4.12c. After 120 s of 
ultrasound treatment, it illustrates a higher cytotoxicity, displaying a viability of about 
5% after 72 h. 
The cell toxicity of silver shell capsules was significantly higher than the particulate 
polymer shell capsules, when the concentration reached 50 capsules/cell. The free 
doxorubicin at this concentration is more toxic than 10 and 20 capsules/cell, showing 
a cell viability of 85% after 24 h, 78% after 48 h and 86% after 72 h. An increase in 
the amount of silver and doxorubicin means the cytotoxicity is increased. The silver 
shell capsules display a viability value of about 20% after 72 h in Fig. 4.12c. After 
ultrasound treatment, the broken silver shells display a cell viability of around 15% 
after 72 h in Fig. 4.12c. Both the doxorubicin-containing silver shell colloidosomes 
and the ones after ultrasound lead to a low cell viability, showing around 5% after 72 
h. 
The toxicity of silver particles to living cells was reported by some researchers as 
well. For example, Yen et al. [153] used murine macrophage cells to test the toxicity of 
different concentrations and sizes of silver nanoparticles. For the concentration of 1 
ppm, there was no significant effect on cell viability. When using a concentration of 
10 ppm, the cell proliferation or viability decreased dramatically. In addition, the 
cytotoxic effect of small size silver nanoparticles (2-5 nm) to macrophages was more 
obvious than that of large size silver nanoparticles (20-40 nm). These conclusions are 
similar to our experimental results. For water-core silver colloidosomes, the high 




In addition, after breaking by ultrasound, the silver shells were broken into small 
pieces resulting in a higher toxicity.  
According to the cell viability results, all the capsule concentration, size and 
composition can determine the final proliferation and death rate of cells. After 
triggering the silver shells using ultrasound, the combined effects of the released 
doxorubicin, the broken silver shell capsule fragments and the possible drug attached 
on the surface of the capsules all may kill cancer cells. It is also clear that the number 





4.3.3.2 Using gold coated colloidosomes  
The cell viability experiment was repeated with the gold shell capsules. As seen in Fig. 4.13a, 
after 24 h, both the particulate polymer shells and free doxorubicin indicate no toxicity to 
cancer cells, showing a cell viability of more than 94% at the concentration of 10 and 20 
capsules per cell, and more than 89% at 50 capsules per cell. The blank water-core gold 
coated colloidosomes results indicate a low cytotoxicity showing the cell viability at more 
than 70% for 10 and 20 capsules per cell, and more than 60% for 50 capsules per cell. After 
using ultrasound to break the gold shells, the cell viability of the broken water-core gold 
shells dropped by about 10% for all capsule concentrations. This suggests that the small 
broken shells are more toxic to the cancer cells compared with the intact gold coated capsules. 
The cell viability of gold coated colloidosomes loading doxorubicin display a very similar 
cytotoxicity to the blank gold shells, with a cell viability of more than 70% for 10 and 20 
Fig. 4.13 Viability of B50 cells mixed with different amounts of particulate polymer shell 
colloidosomes, free doxorubicin, gold shell colloidosomes, gold shell colloidosomes after 240 s 
ultrasound, doxorubicin-containing gold shell colloidosomes and doxorubicin-containing gold shell 
colloidosomes loading doxorubicin after 240 s ultrasound. (a) 24 h, (b) 48 h, and (c) 72 h at 37 °C. The 
error bars show the standard deviations. The ultrasound treatment was operated at a frequency of 20 




capsules per cell and more than 58% for 50 capsules per cell. After ultrasound, the 
doxorubicin-containing gold shell colloidosomes lead to a lower cell viability of 62% for 10 
capsules, 52% for 20 capsules per cell and around 40% for 50 capsules per cell. This suggests 
that both the released doxorubicin and broken gold fragments can kill cancer cells. For free 
doxorubicin, only a higher concentration of capusles, 50 capsules per cell, result in an 
obvious effect on cells. This suggests that the released doxorucin is not enough to kill cells 
at the concentration of 10 and 20 capsules per cell. 
As can be seen in Fig. 4.13a, b and c, at different time points, the gold shells have an effect 
on cell viability. At later times of 48 and 72 h, the cell viability increased compared with 24 
h. This indicates that the gold shells have an inhibiting effect on cell viability, specifically 
at early times, and later this effect is diluted and cells recover and return to proliferation. 
There might be different reasons for the observation. Firstly, cells prefer to initially reject 
any external materials, and they need some time to get used to their environment. It is worth 
mentioning that, after 48 h, all gold samples still display the same trend as seen after 24 h, 
but with a higher cell viability. This suggests that the B50 cells are acclimatizing to the 
capsules with a gold coating and displaying good cell proliferation. Secondly, other factors, 
such as the concentration, size and composition of the gold particles, can influence the final 
proliferation and death rate of cells. Nevertheless, the data suggests that the gold coated 
colloidosomes have no major negative effect on cell viability. The silver coated 
colloidosomes display a higher toxicity. For example, after 72 h, the broken water core silver 
coated colloidosomes show a cell viability of around 40% at a concentration of 10 capsules 
per cell, however, the gold ones show a viability of 70% at the same concentration. 
Compared with silver shell colloidosomes, the gold shells show lower toxicity to cells, and 
lower drug encapsulation efficiency. To find out why gold coated colloidosomes have no 






In this chapter, our study has demonstrated a method for encapsulating an anticancer drug 
using both silver and gold coated colloidosomes. These two types of colloidosomes are 
impermeable for small molecules drugs and can be triggered using ultrasound. After 120 s 
of ultrasound treatment for silver shells and 240 s of ultrasound treatment for gold shells, 
most of the capsules were destroyed into small pieces and only a few survived. We propose 
the possibility to use the metal coated capsules for delivery of anticancer drugs, i.e., 
doxorubicin. For silver coated colloidosomes, at 10 capsules/cell, they have a low 
cytotoxicity, showing a cell viability of more than 90% during the first 24 h and more than 
60% after 72 h. With prolonging the numbers of the capsules, the cytotoxicity of the silver 
shells increases heavily. After triggering the doxorubicin-containing silver shells using 
ultrasound, the combined effects of the released doxorubicin, the broken silver shell capulse 
fragments and the possible drug attached on the surface of the capsules all may kill cancer 
cells. Compared with silver ones, the gold shells seem to be less toxic to cells, and have a 







Chapter 5.  
 
Antibiotic encapsulation - Kanamycin 
 
The results from this chapter have been published in Frontiers in Chemistry: 
Qian Sun, Ziyan Zhao, Elizabeth A. H. Hall, Alexander F. Routh. Metal Coated 
Colloidosomes as Carriers for an Antibiotic. Frontiers in Chemistry, 2018, 6: 196.  
 
5.1 Introduction 
In chapter 4, we demonstrated a method for encapsulating an anticancer drug using both 
silver and gold coated colloidosomes, and tested the cell viability of B50 cancer cells. To 
investigate the application of the metal coated colloidosomes in another biological system, 
Escherichia Coli (E.coli) bacteria were chosen and mixed with colloidosomes which contain 
the antibiotic kanamycin. E.coli have been studied extensively and are an ideal model 
organism. Kanamycin is an aminoglycoside antibiotic that induces its bactericidal effect by 
introducing errors in protein synthesis through tRNA mismatch upon binding to the bacterial 
ribosome [200].  
This chapter describes a method for encapsulating an antibiotic kanamycin using silver or 
gold coated colloidosomes. The colloidosomes are impermeable and can be triggered using 
ultrasound. After triggering the metal shells by ultrasound, the released antibiotic, the broken 
fragments and the possible antibiotic attached on the suface of the capluses may all kill 
E.coli. For a constant concentration of capsules, silver shells display a very slightly higher 
toxicity than gold ones. The gold coated colloidosomes can load a higher concentration of 
kanamycin than silver shells. There are also some interesting morphological changes to the 





5.2 Experimental section 
5.2.1 Materials 
The base latex particles and particulate polymer shell colloidosomes were made in exactly 
the same process as reported in section 2.2.1. The deionized water in all experiments had a 
resistivity of 18.2 MΩ•cm and was produced by a Pure Lab Ultra apparatus. Other chemicals, 
including sodium dodecyl sulfate (SDS, Fisher Scientific), buffer solution pH 10.0 (Sigma-
Aldrich), 4,4’-dithiodibutyric acid (DDA, 95%, Sigma-Aldrich), and kanamycin 
monosulphate (Sigma-Aldrich) were all used as received without purification. The vortex 
mixer was a TopMix FB15024 (Fisher Scientific).  
For cell viability studies, pET-24a (+) plasmid with a kanamycin resistant site (Novagen) 
was transferred into Escherichia Coli BL21 (DE3) competent cells (Novagen). The cells 
were grown in Luria Bertani (LB) Media, which contains 50 μg/mL kanamycin. The LB 
media was prepared with 10 g/L tryptone (mirobiologically tested, Sigma-Aldrich), 5 g/L 
yeast extract (for use in microbial growth medium, Sigma-Aldrich), 10 g/L NaCl (Sigma-
Aldrich), and 1.5% (w/v) Agar powder (Thermo Fisher Scientific).  
  




5.2.2 Antibiotic encapsulation  
Fig. 5.2 shows the fabrication method of kanamycin-containing gold coated colloidosomes. 
A Silverson high shear mixer (model SL2) was used to mix 4 mL Span 80 with 200 mL 
sunflower oil in a 400 mL beaker. The latex particle suspension (11.2 wt% in pH 10 buffer 
solution) was mixed with 12.5 mg/mL kanamycin monosulphate, to get a mixture, which 
contained 5.6 wt% latex particles and 6.25 mg/mL kanamycin monosulphate in buffer 
solution. 2 mL of this mixture was then added into the sunflower oil. After emulsification, 
the mixture was heated in a water bath at 50 ± 0.5°C. This allows the latex particles to merge 
into a smooth shell. 
After sintering, 20 mL of the emulsion mixture was centrifuged at 2500 rpm for 10 min at 
20°C. The oil was removed via pipetting and 20 mL of 1 wt % aqueous solution of HAuCl4 
and 2 mL of 1 wt% aqueous SDS solution were added, and the microcapsules were 
redispersed in the aqueous phase using a vortex mixer. Then 2 mL of L-ascorbic acid 
solution (15 wt% in water) was added to the tube and rested for 1 h to allow the gold forming 
reaction. After the gold forming reaction, the mixture was centrifuged at 1500 rpm for 2 min 
at 20°C to recover the sediment and the supernatant was removed via pipetting. The resulting 
gold coated colloidosomes, loaded with kanamycin, were washed and redispersed, using a 
0.1 wt% SDS solution, used to avoid colloidosome aggregation. 
The SDS surfactant solution affects the cell viability. However, without the surfactant the 
capsules are heavily aggregated in water. Consequently, we used 4,4’-dithiodibutyric acid 




(DDA) to modify the capsule surfaces, which allows the metal shell capsules to disperse in 
pure water. A known mass of silver or gold coated colloidosomes were dispersed in 0.5 wt% 
4,4’-dithiodibutyric acid (DDA) in ethanol and then gently mixed by a magnetic stirrer for 
48 hours at room temperature. After the reaction, the whole mixture was centrifuged at 1500 
rpm for 2 min. The supernatant was removed using a pipette. The modified capsules were 
washed and redispersed three times using ultra-pure water. 
To make kanamycin-containing silver coated colloidosomes, the method is similar to that 
for the gold shell capsules. For silver shells, 24 mL of AgNO3 solution (0.1 wt% in water) 
and 2 mL of SDS (1 wt% in water) were added in each tube. Then 2 mL of L-ascorbic acid 
solution (15 wt% in water) was added and rested for 1 h allowing the silver forming reaction. 
5.2.3 Release by ultrasonic treatment 
Remote activation of microcapsules was conducted using an ultrasonic probe operating at a 
frequency of 23 kHz and 50W. To break the metal shell capsules, the suspension of 
microcapsules was subjected to ultrasound sonication, performed using an ultrasonic 
processor (Sanyo soniprep 150). The probe was placed into a 5 mL capsule suspension in a 
50 mL plastic tube. An ice bath was applied to ensure that the temperature change of the 
capsule suspension was less than 5°C. 
5.2.4 Cell viability test 
The kanamycin resistant E.coli BL21 (DE3) cells were grown for 16 hours in 10 mL LB 
medium supplemented with 50 μg/mL kanamycin. 100 μL of the overnight culture were then 
transferred to 50 mL falcon tubes containing the same LB medium for inoculation. The 
growth of cells was monitored by measuring the optical density at 600 nm (OD600) of the 
cell culture using a UV-Visible spectrophotometer (Infinite M200 Tecan). The treatments 
were added to the cells, when the culture OD600 was approximately 0.7. For blank kanamycin 
measurements, 1 mL of kanamycin solution at various concentrations was added to the cells 
to obtain final concentrations between 50 and 5000 μg/mL. For metal shell capsules, blank 
silver/gold shells and silver/gold shells loading kanamycin with intact shells were added to 
the cell culture, achieving a final concentration in the range of 7.1 × 105 to 3.5 × 108 
capsules/mL. A hemocytometer (a counting chamber) was used for determining the number 




concentrations of ultrasound-broken capsules were added to the cell culture. Treated cells 
were then grown for 24 hours. All cultures were shaken at 37 ºC, 225 rpm in a multitron 
shaker (Infors HT). The resulting cell cultures were then diluted in LB media and spread 
evenly on a 90 mm LB Agar plate supplemented with 50 μg/mL kanamycin, to result in 30-
300 CFU per agar plate. The plates were then grown at 37 ºC in an incubator (Heraeus 
Instruments) for 16 hours before the CFU for each plate was counted.  
5.2.5 Sample characterization 
The gold and silver coated colloidosomes were characterised using SEM and EDX. The 
equipment was the same as described in section 2.2.6. The growth of cells was monitored 
by measuring the optical density at 600 nm (OD600) of the cell culture using a UV-Visible 







5.3 Results and discussion 
5.3.1 Antibiotic encapsulation  
5.3.1.1 Using gold coated colloidosomes 
Fig. 5.3a to 5.3c show SEM images of kanamycin-containing gold coated colloidosomes. It 
can be seen that the particulate polymer shells were fully covered by gold particles. After 
loading kanamycin, the morphology of the gold shells does not significantly change, 
compared with the water-core gold coated colloidosomes in Fig. 2.17, and the gold shell 
capsules remain spherical. Fig. 5.3d shows the corresponding EDX image which has high 
gold peaks, suggesting that the particles surrounding the surface of the colloidosomes are 
gold. There are also carbon and oxygen peaks, arising from the particulate polymer shell. 
The aluminium and copper peaks were caused by the SEM stub. To release the encapsulated 
drug, ultrasound was used to trigger the capsules. As shown in Fig. 5.3e, after 480 s 
sonication, only a few colloidosomes survived and there were a large number of small pieces 
of broken shell. For this experiment, we used a longer time in order to break most of the 
capsules, compared with the time previously reported for water-core gold shell 
colloidosomes in section 2.3.3.2.  
Fig. 5.3 (a) (b) (c) SEM and (d) EDX images of kanamycin-containing gold coated colloidosomes, 
and (e) the same kanamycin-containing gold coated colloidosomes after ultrasound treatment, 




5.3.1.2 Using silver coated colloidosomes 
Fig. 5.4a to 5.4c show the SEM image of the silver coated colloidosomes which contained 
kanamycin. As can be seen, the particulate polymer shells were fully covered by sheet-like 
silver particles. After loading kanamycin, the morphology of the silver shells changes from 
the water-core silver shell capsules shown in Fig. 2.13. The sheet-like silver particles, 
surrounding the surface of the particulate polymer shells, were thinner and some silver sheets 
became hollow at the edge. In the silver forming process, the kanamycin may affect the 
silver ions converting into metallic silver. This is likely because kanamycin might associate 
with the silver precursor [201] and prevent it from forming shell shaped capsules.  
Fig. 5.4d shows the corresponding EDX image which has high silver peaks. The sodium and 
sulfur peaks were caused by the SDS surfactant. As shown in Fig. 5.4e, after 240 s sonication, 
most of the silver coated colloidosomes are broken into fragments. For this experiment, we 
also used a longer time in order to break most of the capsules, compared with the time 
previously reported for water-core silver shell colloidosomes in section 2.3.3.1. 
Fig. 5.4 (a) (b) (c) SEM and (d) EDX images of kanamycin-containing silver coated colloidosomes, 
and (e) the same kanamycin-containing silver coated colloidosomes after 240 s of ultrasound 




Fig. 5.5 shows SEM images of the silver coated colloidosomes encapsulating varying 
amounts of kanamycin. When the original kanamycin concentration was increased to 25.0 
mg/mL, the silver particles became thinner. When the concentration increased to 50.0 
mg/mL, there was no silver shell, just separate sheet-like silver particles aggregated. 
However, for gold shells, there was no obvious effect of kanamycin concentration as shown 
in Fig. 5.5d.  
  
Fig. 5.5 SEM images of the silver coated colloidosomes using varying amounts of kanamycin to 
produce the metal shells: (a) 12.5 mg/mL, (b) 25.0 mg/mL, (c) 50.0 mg/mL, and (d) gold coated 




5.3.2 Cell viability test 
The application of the metal coated colloidosomes as small molecule drug carriers was 
investigated in a bacteria system. The CFU/mL data in Fig. 5.6 to 5.8 are calculated by 
counting the average number of the diluted cell colonies. The standard error of the results is 
shown by the error bars. 
5.3.2.1 Free kanamycin cell viability test 
Fig. 5.6 shows the colony forming units results obtained after 24 h incubation of E.coli 
bacteria with different concentrations of free kanamycin. As can be seen, at a concentration 
of 50 and 100 μg/mL kanamycin, the bacteria grew to 1.2 × 108 CFU/mL. When the 
concentration increased to 150 μg/mL, the numbers of CFU dropped to 5.7 × 107 CFU/mL. 
When the concentration increased to 200 μg/mL, the result was increased slightly to 6.6 × 
107 CFU/mL, although within the error of the experiment. The E.coli strain being 
investigated contains a pET-24a(+) plasmid with a kanamycin resistant gene, which 
produces aminoglycoside modifying enzymes. Such strains survive the kanamycin treated 
media at low drug concentrations. Therefore, by adding a certain amount of kanamycin, we 
can ensure that the cells being grown are the kanamycin resistant cells and are not 
contaminated by any environmental bacteria. A low concentration of kanamycin shows a 
beneficial effect for cell growth. With an increasing amount of kanamycin, the inhibition of 
Fig. 5.6 Colony forming units results obtained after 24 h incubation of E.coli bacteria with different 




cells increased. There is a complete inhibition for E.coli at 5000 μg/mL kanamycin, when 
nearly all of the cells were killed. 
5.3.2.2 Gold coated colloidosomes cell viability test 
Fig. 5.7 shows the cell viability results obtained after 24 h incubation of E.coli bacteria with 
different number concentrations of water-core gold coated colloidosomes, water-core gold 
coated colloidosomes after ultrasound, kanamycin-containing gold coated colloidosomes, 
and kanamycin-containing gold coated colloidosomes after ultrasound. In order to break the 
gold shells, ultrasound was applied for 480 s, before adding the resulting solution to the 
bacteria. 
As seen in Fig. 5.7, there was a CFU decrease in all of the gold shell treated samples 
compared to the blank E.coli culture with 50 μg/mL kanamycin. This indicates the gold 
Fig. 5.7 Colony forming units results obtained after 24 h incubation of E.coli bacteria with different 
concentrations of water-core gold coated colloidosomes loading with and without kanamycin, water-
core gold coated colloidosomes after ultrasound, kanamycin-containing gold coated colloidosomes, 
and kanamycin-containing gold coated colloidosomes after ultrasound. The error bars show the 
standard deviations. The ultrasound treatment was operated at a frequency of 23 kHz and power 




coated colloidosomes are toxic to the E.coli culture. The toxicity increases with increasing 
concentration of gold coated colloidosomes. With a concentration of 7.06 × 105 capsules/mL 
the toxic effect from the colloidosomes after ultrasound results in a cell viability of 
approximately 6.7 × 107 CFU/mL, a 25 % drop from the case without ultrasound. Increasing 
the concentration of capsules, the toxicity becomes more obvious. When the number of the 
capsules reaches to 3.53 × 108 capsules/mL, the encapsulation of kanamycin had minimal 
extra benefit, with the capsules themselves hindering the cell viability. 
5.3.2.3 Silver coated colloidosomes cell viability test 
Fig. 5.8 shows the cell viability results obtained after 24 h incubation of E.coli with different 
amounts of water-core silver coated colloidosomes, water-core silver coated colloidosomes 
after ultrasound, kanamycin-containing silver coated colloidosomes, and kanamycin-
containing silver coated colloidosomes after ultrasound. Before rupture, there is minimal 
Fig. 5.8 Colony forming units results obtained after 24 h incubation of E.coli bacteria with different 
concentrations of water-core silver coated colloidosomes, water-core silver coated colloidosomes 
after ultrasound, kanamycin-containing silver coated colloidosomes, and kanamycin-containing silver 
coated colloidosomes after ultrasound. The error bars show the standard deviations. The ultrasound 
treatment was operated at a frequency of 23 kHz and power output of 50 W for 240 s in an ice bath, 




toxicity difference between the empty and kanamycin containing capsules. After ultrasound, 
the kanamycin has a significant effect on cell viability. In order to break silver shells, the 
ultrasound was applied for 240 s before adding the resulting solution into the bacteria.  
The effect of the silver coated colloidosomes on cell viability shows a similar trend to the 
gold capsules, with the cell viability decreasing, compared with the E.coli control. The effect 
on cell viability of silver coated colloidosomes loading kanamycin after ultrasound was most 
dramatic because of the released antibiotic and the possible antibiotic attached on the suface 
of the broken shells. For the lowest concentration of silver shells, the cell viability after 
kanamycin released dropped by 34% compared with other capsules. Increasing the 
concentration of capsules, the toxic effect becomes enhanced.  
Both the silver and gold shells colloidosomes are toxic to this bacterial system. With a low 
concentration of 7.06 × 105 capsules/mL, the difference of toxicity between gold and silver 
colloidosomes is not significant. Increasing the concentration of capsules, the cell viability 
is slightly different. For example, at a concentration of 3.53 × 108 capsules/mL, for gold 
shells after ultrasound, there are around 3 × 107 CFU remaining, and for silver shell capsules 
after ultrasound around 2 × 107 CFU remain. This slight difference is likely to be because 
the silver shells, especially silver shell fragments in nano-size as well as any silver ions are 
toxic to biological systems and are leading to the death of bacteria. [196, 197]  
For this E.coli bacterial system, the effect of nano-size silver shell fragments on cells is not 
very obvious, compared with the B50 cancer cell system in chapter 4. In addition, the cell 
viabilities between different concentration samples are not obvious enough and also with a 
relatively large error bar. So, this chapter is only showing the qualitative results of the 







In this chapter, we demonstrate a method for encapsulating an antibiotic kanamycin using 
gold or silver coated colloidosomes, and then triggered the capsules using ultrasound. To 
investigate the application of the capsules in a bacterial system, E.coli bacteria were chosen 
as a model organism. After triggering the metal shells by ultrasound, the released antibiotic, 
the broken fragments, and some antibiotic which may be attaching onto the capsule surface, 
all may kill E.coli. Both the silver and gold shells colloidosomes are toxic to this bacteria 
system. Compared with silver coated colloidosomes, gold ones can load a higher 






Chapter 6.  
 
Conclusions and future work 
 
6.1 Conclusions 
In this thesis, particulate polymer shell colloidosomes coated with a silver or gold shell were 
prepared and investigated to load drugs and use them as drug carriers. After optimizing the 
reaction conditions, the silver coated colloidosomes were prepared by making the particulate 
polymer shell first, then reacting L-ascorbic acid with silver nitrate in the wash solution. 
The particulate polymer shells are fully covered by sheet-like silver particles to form 
a silver shell, which may form a film to improve the strength and permeability of the 
colloidosomes. Similar to the silver shells, the gold coated colloidosomes were prepared 
by making the particulate polymer shell first, then reacting L-Ascorbic acid with HAuCl4 in 
the wash solution. The gold shells are spherical and cover the particulate polymer shells, 
which may also improve the strength and permeability of the colloidosomes. Both these two 
types of colloidosomes were successfully demonstrated to encapsulate Allura Red AC dye 
solution and the shell of these structures was ruptured using ultrasound treatment, operating 
at a frequency of 20 kHz and power output of 50 W. The encapsulation efficiency of silver 
coated colloidosomes is 22.7%, and 15.7% for gold coated colloidosomes.  
To investigate the metal shell capsules for biological targeting applications, the 
colloidosomes were modified using 4,4’-dithiodibutyric acid and combined with rabbit 
antigen. The Surface Plasmon Resonance biosensor, which was used for an immunoassay 
sensitivity measurement, proved that the two types of modified colloidosomes combined 
with the rabbit IgG can be captured by the anti-rabbit IgG, which was immobilized on the 
gold film of SPR surface. After attaching on the gold film, both types of colloidosomes can 
be ruptured using ultrasound treatment, operating at a frequency of 20 kHz and power output 
of 50 W. For the SPR experiment, in order to achieve a higher loading efficiency of the metal 




research. The functional modified silver or gold coated colloidosomes are promising for 
many future medical applications including targeted carriers for small bioactive molecules 
with controlled drug delivery and externally triggered release. 
To use the capsules as drugs carriers, our study demonstrates a method for encapsulating an 
anticancer drug, doxorubicin. The doxorubicin-containing metal coated colloidosomes are 
impermeable to small molecule drugs and can be triggered using ultrasound, operating at a 
frequency of 20 kHz and power output of 50 W.  After 120 s of ultrasound treatment for 
silver coated colloidosomes and 240 s for gold coated colloidosomes, most of the capsules 
were destroyed into small pieces and only a few survived. In addition, we also tried high 
intensity focused ultrasound with a frequency of 2.65 MHz and a power of 6 W to break the 
metal coated colloidosomes. Some of the metal shells were deformed and broken, but there 
were still a large percentage of intact metal shell colloidosomes, when using a HIFU 
treatment for a few minutes. Further research needs to be done to improve the release 
efficiency using HIFU for the metal capsules. We then tested the cell viability of B50 cancer 
cells and propose the possibility to use the metal shell capsules for delivery of anticancer 
drugs, i.e., doxorubicin. For silver coated colloidosomes, at 10 capsules/cell, a cell viability 
of more than 90% during the first 24 h and more than 60% after 72 h are seen. Increasing 
the number of capsules, the cytotoxicity of the silver shells increases heavily. It is also clear 
that all the capsule concentration, size and composition can determine the final proliferation 
and death rate of cells. After triggering the silver shells using ultrasound, the combined 
effects of the released doxorubicin, the broken silver coated capsule fragments and the 
possible drug attached on the surface of the capsules all may kill cancer cells. Compared 
with silver ones, the gold shells show less toxicity to cells and have no major negative effect 
on cancer cells, but a lower drug loading efficiency.  
In addtion, we demonstrate a method for encapsulating an antibiotic, kanamycin, using gold 
or silver coated colloidosomes. After triggering the metal shells by ultrasound, the released 
antibiotic, the broken fragments and the possible antibiotic attached on the suface of the 
capluses may all kill E.coli. For the same concentration of capsules, silver shells display a 
slight higher toxicity compared with gold shell capsules. However, the gold coated 
colloidosomes can load a higher concentration of kanamycin. 
Overall, both the aqueous core silver and gold coated colloidosomes are successful for long 




with proteins to achieve biological targeting. Both silver and gold shell colloidosomes are 
impermeable and can seal the drugs. Silver shells result in a lower cell viability compared 
with gold shells. For triggering the capsules, we have demonstrated the use of ultrasound 
treatment. 
 
6.2 Limitation and future work 
Traditional particulate polymer shell colloidosomes leak low molecular weight encapsulated 
materials due to their intrinsic shell permeability. To solve this problem, we have 
demonstrated growing a second inorganic shell, leading to the successful long term 
encapsulation of small molecule materials. The encapsulation efficiency of silver coated 
colloidosomes is 22.7%, and 15.7% for gold coated colloidosomes. Although the silver shell 
can change the permeability of the particulate polymer shells, we also decreased the 
encapsulation efficiency to a certain extent, which is lower than some drug delivery 
materials, for example, a loading efficiency between 22.4% and 45.6% for mesoporous 
PLGA-SiO2
 [181]. So, it is clear that the further optimisation possibilities exist.  
In addition, in the SPR experiments, the interrogation zone under the light spot covers a 
relatively low and different numbers of capsules, so there were relatively large error bars in 
the SPR wavelength shift bar chart and only a few nanometres red shift for SPR wavelength. 
In order to produce an improvement in sensitivity for capsule detection, we can try to modify 
the SPR surface, such as using gold nanoparticles or silica nanoparticles, to enhance the 
signals. [166]  
More importantly, in order to use the impermeable capsules as drug carriers, there is a need 
to reduce the overall size when used for in vitro and in vivo delivery [202]. Therefore, as well 
as encapsulation of small molecule materials, we also wish to make nano-size colloidosomes. 
Currently, we use latex particles with a diameter of 153 nm for capsules with a diameter of 
1-2 μm. To achieve the smaller size, it will require making smaller emulsion droplets 
stabilized with latex particles. The first step is to review and select latex particles, such as 
monodisperse polystyrene lattices [203]. For the organic phase, we will start with sunflower 
and vegetable oils. The next step is to emulsify the latex suspensions in the oil phase. To 




mixer. Preliminary investigations indicate that this does not result in the order of magnitude 
reduction in droplet size.  
We will investigate using a rotating packed bed (RPB) to increase intensification of 
micromixing and to make small emulsion droplets. Fig. 6.1 shows a schematic diagram of 
the device. A RPB can generate a high gravity environment to strongly intensify 
micromixing and mass transfer by the high shearing force. This will produce high-quality 
emulsions via the formation of ultrafine and uniform oil droplets. [204, 205] In a typical RPB, 
there is a motor with a rotating shaft which is combined with the packing part. When the 
shaft starts rotating, it leads to a rotation of the packing part as well. There are some small 
holes on the inlet metal tubes. Normally, the reactant is input by a peristaltic pump, and then 
goes through the small holes on the inlet, reaching the packing part. The packing, with a 
high rotating speed, can strongly intensify the mixing and the shear force can separate the 
reactant droplets creating more reaction surface areas. Finally, the products will be collected 
from a liquid outlet.  
We will also try more conventional emulsification methods, such as a high-shear mixer, 
ultrasound and a microfluidic reactor. After collecting the colloidosomes, the droplet size 
will be measured by dynamic light scattering (DLS), scanning electron microscopy (SEM) 
and transmission electron microscopy (TEM). 
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